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ABSTRACT
Enteroviruses have a tropism for muscle cells and have been linked to the 
development of CFS. Muscle abnormalities made worse by exercise are one of the 
major symptoms in CFS and abnormalities in cellular energy levels suggestive of an 
impairment of mitochondrial function have been reported following virus infection. 
A mitochondrial disorder precipitated by a virus infection has been suggested as the 
cause for the unexplained fatigue in CFS. The work presented in this thesis provides 
a potential link between CFS and viral infection by suggesting that the energy 
abnormalities in patients diagnosed with CFS may be due to a virus-induced 
impairment of the mitochondrial electron transport chain. A novel effect on cellular 
respiration caused by poliovirus infection was shown. The effect of poliovirus 
infection on mitochondrial function was investigated in COS-1 and T47D 
mammalian cells. In both cases a rapid decrease in total cell respiration was 
observed, and this was attributed to an inhibition of mitochondrial respiration. In 
parallel with the inhibition of mitochondrial respiration, the activity of succinate 
dehydrogenase was impaired during poliovirus infection. This shows that poliovirus- 
induced inhibition of cellular respiration occurs primarily through inhibition of 
electron flow at complex II of the mitochondrial respiratory chain. Infected cells 
also showed increased staining with the fluorescent lipophilic cationic mitochondrial 
probe tetramethylrhodamine ethyl ester showing that the impairment of respiration 
does not lead to a collapse of mitochondrial membrane potential and mitochondrial 
permeability transition pore opening. The involvement of the poliovirus non- 
structrural proteins 2B and 2BC was also investigated. Expression of 2B, but not 
2BC, in COS-1 cells also caused a significant increase in mitochondrial membrane 
potential indicating that 2B may he responsible for the increased mitochondrial 
membrane potential during poliovirus infection. Additionally, work to generate 
antibodies specific for these proteins was initiated in order to investigate their 
intracellular localisation.
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Chapter 1
INTRODUCTION
Enteroviruses have a tropism for muscle cells and have been implicated in the 
aetiology of cbronie fatigue syndrome (CFS). Abnormal mitochondria have been 
reported in CFS patient muscle biopsies and defects in energy supply have also been 
suggested as a possible cause of this syndrome. Amongst several possibilities is the 
chance that the disease might be triggered by a virus infection in muscle. This 
project set out to investigate the possible effect of enterovirus infection on cell 
function, and in particular energy generation.
1.1 Chronic fatigue syndrome
Cbronie fatigue syndrome (CFS) is a chronic condition of uncertain aetiology and 
lacking an identified definite pathological abnormality (Bock & Whelan, 1993). The 
illness is not associated with pathognomonic physical or laboratory abnormalities 
and is not a cause of premature death. Definitive treatments for this illness remain to 
be identified. Several synonyms have been used to describe the epidemic and 
endemic forms of this disease that can have up to seventy symptoms and signs. The 
common synonyms are: post-viral fatigue syndrome (PFS), favoured in Great 
Britain, cbronie infectious mononucleosis, favoured in U.S.A., and benign or 
epidemic myalgic encephalomyelitis (ME). The epidemic type of CFS has been 
reported infrequently since the late 1950s (Holmes et a l, 1987). Synonyms used to 
identify the epidemic form include epidemic neuromyaestbenia, Adelaide epidemic. 
Royal Free disease, and Icelandic disease indicating outbreaks in various 
geographical areas. The synonyms used for the endemic form have been chosen on 
the assumption that infective agents may be responsible for the syndrome and they 
include myelgic encephalomyelitis, idiopathic chronic fatigue syndrome, chronic
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infectious mononucleosis, “Yuppie” flu and Epstein-Barr disease (Spracklen, 1988; 
Shorter, 1993).
1.1.1 Case definition
Case definitions have been developed by the United States Centers for Disease 
Control and by British and Australian investigators (Holmes et a l, 1988; Lloyd et 
al., 1990; Sharpe et al., 1991). Developing an operational definition of CFS remains 
a problem because the concept of fatigue is unclear. In 1994 a revised case 
definition was published (Fukuda et a l, 1994). This definition is as follows:
“ A case of the chronic fatigue syndrome is defined by the presence of the following:
1) clinically evaluated, unexplained, persistent or relapsing chronic fatigue that is of new or 
definite onset (has not been lifelong); is not the result of ongoing exertion; is not 
substantially alleviated by rest; and results in substantial reduction in previous levels of 
occupational, educational, social, or personal activities; and
2) the concurrent occurrence of four or more of the following symptoms, all of which must 
have persisted or recurred during 6 or more consecutive months of illness and must not 
have predated the fatigue: self-reported impairment in short-term memory or 
concentration severe enough to cause substantial reduction in previous levels of 
occupational, educational, social, or personal activities; sore throat; tender cervical or 
axillary lymph nodes; muscle pain, multijoint pain without joint swelling or redness; 
headaches of a new type, pattern, or severity; unreffesbing sleep; and postexertional 
malaise lasting more than 24 hours.” (Fukuda et al., 1994).
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The inclusion of psychiatric illnesses in the diagnosis of CFS is controversial 
amongst physicians. However, pre-existing or co-existing psychiatric disease does 
not exclude a person from inclusion in the CFS diagnostic group if the major criteria 
of the disease are met and a formal psychiatric evaluation is performed (Bock & 
Whelan, 1993).
1.1.2 Clinical epidemiology and presentation
Epidemiologically CFS occurs both sporadically and epidemically with sudden onset 
of multiple cases being reported in the U.S.A., Europe, Australasia, and South Africa 
since 1934, but the epidemic form seems to have been rare since the late 1950s 
(Acbeson, 1959; Shorter, 1993; Briggs & Levine, 1994). Most CFS patients are 20- 
50 years of age; women are affected more commonly than men. Group studies have 
shown that patients diagnosed with CFS are predominantly white between the ages 
of 20-40 years of age (Sbafran, 1991; Gunn et al., 1993; Komaroff, 1993). However, 
some studies have shown that CFS may also present itself in adolescents (Komaroff, 
1993; Bell et al., 1994). While there are no ethnic differences, CFS tends to occur in 
cooler climates and higher socio-economic groups though this may be an artefact as 
suggested by some studies. (Spracklen, 1988; Sbafran, 1991; Gunn et a l, 1993; 
Levine, 1994).
Patients are usually physically very active before the onset of illness but afterwards 
are unable to perform any physical activity; even the modest physical exertion 
produces a striking exacerbation of many of their symptoms and in 30-70% of 
patients there is worsening of their fatigue that can last for at least 6 months 
(Sbafran, 1991; Bock & Whelan, 1993). Table 1.1 summarises the symptoms
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frequently reported in CFS over the years. The course of illness runs for 2-5 years 
but occasionally it may last more than 10 years.
Symptom Frequency (%)
Fatigue 100
Impaired cognition 50 - 85
Depression 50-85
Pharyngitis 50-75
Anxiety 50-70
Post-exertional malaise 50-60
Pre-menstrual worsening 50-60
Stiffness 50-60
Visual blurring 50-60
Nausea 50 - 60
Muscle weakness 40-70
Arthralgias 40 - 50
Tachycardia 40-50
Headaches 35-85
Dizziness 30-50
Paraestbesias 30-50
Dry eyes 30-40
Dry mouth 30-40
Diarrhoea 30-40
Anorexia 30-40
Cough 30-40
Finger swelling 30 - 40
Night sweats 30-40
Painful lymph nodes 30-40
Rash 30-40
Low-grade fever 20-95
Myalgias 20 - 95
Sleep disorder 15-90
Table 1.1 Frequency of symptoms reported in CFS. (Taken from Komaroff, 
1993)
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Most patients report a gradual recovery with relapses precipitated by over-exertion. 
The young and those who receive good medical attention have the best chance of 
recovery. The social consequences of the illness can be severe. The patients feel 
personally deficient, and alienated and many cut down their social life (Ware, 1993).
1.1.3 Aetiology
The aetiology of CFS is not known but the occurrence of the endemic forms 
described above must suggest that in some cases at least the cause may be an 
infection. Extensive research has been undertaken to determine whether or not one 
or more biological agents cause CFS. However, no agent has been shown to satisfy 
the required criteria. Immunologic abnormalities have been found in individual 
patients with the syndrome suggesting an association between CFS and altered 
immune function (Klimas et a l, 1990; Bucbwald & Komaroff, 1991; Linde et a l, 
1992; Vojdani & Lapp, 1999). However, the significance of these abnormalities 
remains uncertain since most of them do not appear in the majority of patients, the 
heterogeneity within patient groups limits the interpretation of the available assays, 
and evidence establishing a link between abnormal immunity (humoral and cellular) 
and CFS has yet to be found (Sbafran, 1991; Lloyd et a l, 1993).
Some of the reported associations of the illness, such as the abrupt onset of a fever, 
suggest that a viral infection may be the cause. Viruses that have been associated, 
but not yet widely accepted or established, with the syndrome include the 
enteroviruses, retroviruses, human herpesviruses, and Boma disease virus (Ablasbi et 
a l, 2000; Martin, 1997; Takabasbi et a l, 1996; Galbraith et a l,  1995; Cunningham
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et al., 1991; DeFreitas et al., 1991; Cunningham et al., 1990). This research project 
addressed the possibility of enterovirus involvement, in particular poliovirus, and 
these viruses will be considered in more detail in following section.
1.1.3.1 Enteroviruses
Support for an aetiologic role of enteroviruses in CFS is derived mainly from studies 
in the United Kingdom where the syndrome is often referred to as PFS. The 
definition of post-viral varies from 24 hours after infection to one month after the 
initial episode. However, if the fatigue persists for 6 months or longer then the term 
'chronic' is used (Behan et a l, 1985; Arcbard et a l, 1988; Behan & Behan, 1988; 
Yousef et a l, 1988; Cunningham et a l, 1990; Gow et a l, 1991; Bowles et a l,  1993; 
Galbraith et a l, 1995; Galbraith et a l, 1997). Enteroviruses are the group of viruses 
most consistently associated with the syndrome. They have been found in the gut, in 
stool and blood samples and in muscle biopsies of CFS patients enforcing the 
suggestion that these viruses may be implicated in CFS (Behan et a l,  1985; 
Spracklen, 1988; Behan et a l, 1993).
Outbreaks of PFS have often been related temporally to the occurrence of 
poliomyelitis and studies of patients have indicated that a virus similar to the 
poliomyelitis virus may indeed be involved (Acbeson, 1959; Behan & Behan, 1988; 
Shorter, 1993). A condition very similar to CFS and termed post-polio fatigue has 
been related clinically, historically or physiologically to poliovirus (PV) infection 
(Behan et a l, 1993; Bruno et a l, 1998). Abnormal responses to poliomyelitis 
vaccination were observed in patients who bad developed PFS in the outbreak of 
Akureyri fever (epidemic neuromyasthenia) which took place in Iceland in the
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1950s, (Behan et al., 1993). Although no PV was isolated, these responses suggest 
indirectly that one was in fact in circulation at that time and that PFS patients may 
have already been exposed to such an agent. A recent study carried out on patients 
with diagnosed CFS showed that administration of poliovirus vaccine led to altered 
immune reactivity and virus clearance in these patients suggesting that they bad 
already been exposed to a virus possibly related to polio (Vedbara et al., 1997). That 
shared antigenic determinants with the poliomyelitis vaccine virus. However, CFS is 
probably not due to the poliomyelitis polioviruses since the number of patients with 
CFS has not been reduced since immunisation was introduced, although a related but 
distinct virus cannot be excluded.
Coxsackie B viruses have also been implicated with CFS. Chronic shedding of these 
viruses has been seen in the faeces of CFS patients, enteroviral RNA sequences have 
been found in muscle biopsies and serological studies have shown elevated 
neutralising antibodies to these viruses (Bell et al., 1988; Yousef et al., 1988; Behan 
et al., 1985; Cunningham et al., 1990; Doesett et al., 1990; Beban et al., 1993; 
Galbraith et al., 1997). Search for enteroviruses in muscle of patients diagnosed with 
CFS bas shown enteroviral genomic material in the patients' muscles (Arcbard et al., 
1988; Cunningham et al., 1990; Gow et al., 1991; Bowles et al., 1993). However, 
none of these findings has proved to be consistent.
1.1.3.2 Muscle abnormalities
Muscle fatigue made worse by exercise is one of the major symptoms in patients 
with CFS. Single-fiber electromyography has shown muscle membrane defects in 
patients with CFS (Jamal & Hansen, 1989). Nuclear magnetic resonance 
spectroscopy has shown that the muscle in some patients diagnosed with CFS
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undergoes premature intracellular acidosis during exercise and has a prolonged 
recovery period indicating dysfunction of respiratory metabolism (Arnold et ah, 
1984; Yonge, 1988). Also, the intracellular concentration of ATP has been reported 
to be reduced in CFS patients undergoing exercise (Wong et al., 1992). 
Additionally, clinical studies have shown that patients with CFS demonstrate reduced 
aerobic work capacity (Riley et al., 1990). Elevated serum creatine kinase, a marker 
for muscle damage when above normal levels, has also been reported in patients with 
CFS (Arnold et al., 1984; Behan et al., 1991). All the above observations are 
suggestive of mitochondrial abnormalities in the muscles of CFS patients.
Ultrastructural analysis has revealed morphological abnormalities in muscle 
mitochondria consisting of branching and fusion of the cristae, which produce the 
appearance of “compartmentalisation” within the mitochondria and increase in 
mitochondrial size (Behan et al., 1985; Behan et al., 1991). Furthermore, patients 
with CFS have been found to exhibit a deficiency in acylcamitine indicating an 
energy metabolism abnormality and a fatty acid metabolic dysfunction in the 
mitochondria (Kuratsune et al., 1994). A mitochondrial disorder precipitated by a 
virus infection has been suggested as the cause for the unexplained fatigue in CFS 
although the data published so far is not conclusive (Behan et al., 1991; Behan et al., 
1993).
1.2 Human poliovirus
Enteroviruses have a tropism for muscle cells and have been implicated in the 
aetiology of chronic fatigue syndrome as mentioned above. This project used the
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Mahoney strain of type 1 PV and examined the effects of replication and virus non- 
structural (2B and 2BC) proteins on mitochondria.
PV is the aetiologic agent of poliomyelitis, a human disease affecting the central 
nervous system and leading to destruction of motor neurones. An 18* Dynasty 
(1580-1350 BC) Egyptian carving is the earliest record of poliomyelitis. It shows a 
young man with a withered, shortened leg and his foot is held in a position typical of 
flaccid paralysis associated with poliomyelitis (Melnick, 1983). Although PV was 
first identified as "’"'poliomyelitis virus"" in 1909, by inoculation of monkeys with 
specimens from cases of paralytic poliomyelitis (Melnick, 1983), its importance as a 
cause of human disease was not appreciated until 1949 when Enders and his co­
workers showed that different strains of PV could be grown in cell cultures (Enders 
et al., 1949). This breakthrough in virology led to the development of formalin- 
inactivated vaccines by Salk (Salk, 1953) and live-attenuated vaccines by Sabin 
(Sabin, 1955). In 1953 the name poliovirus was universally adopted following a 
recommendation by the Virus Subcommittee of the International Association of 
Microbiological Societies (von Magnus et al., 1955).
1.2.1 Classification
Classification of viruses into families has in the past been mainly based on virion 
morphology, the nature of the genomic nucleic acid and replication process. Genera 
are defined largely on the basis of physiochemical properties, such as virion density 
and acid sensitivity. This is being increasingly superceded by genomic analysis. PV 
belongs to the genus Enterovirus of the Picornaviridae, a family of small, non­
enveloped, positive-strand RNA viruses. Five other genera are currently included in
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this family of viruses, namely: Cardiovirus, Rhinovirus, Hepatovirus, Aphthovirus 
(Santti et al., 1999; Hyypiâ et al., 1997) and Parechoviruses. The addition of three 
new genera to classify three viruses that have been given the status of unassigned 
species: Equine rhinitis B virus (formerly Equine rhinovirus 2), ‘Aichi-like viruses ’ 
and Porcine teschovirus (formerly Porcine enterovirus 7), has been proposed by the 
Institute for 7\jiimal Health, Pirbright Laboratory, Woking, United Kingdom, and 
awaits formal acceptance by the ICTV Executive Committee (King et al., 1999).
Enteroviruses are found in humans and animals. Enteroviruses of animals have 
generally been classified by host species, e.g. porcine enteroviruses, bovine 
enterovirus and swine vesicular disease virus. Human enteroviruses are subgrouped 
into PV, coxsackieviruses, echoviruses and enterovirus types 68-71 (Table 1.2). 
Three immunologically distinct serotypes of PV (type 1, type 2 and type 3) have 
been recognised that share many biological and structural properties (Toyoda et al., 
1984; Melnick, 1990; Minor et al., 1990).
Serotypes Members
3 Human PV 1,2 ,3
23 Human coxsackie A1-22,24
6 Human coxsackie B 1-6
30 Human echoviruses
4 Human enterovirus types 68-71
Table 1.2 Human enteroviruses.
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1.2.2 Viral pathogenesis
Our knowledge of how PV produces disease (e.g. poliomyelitis) in a host is limited. 
However, the pathologic consequences of acute and limited infection in vivo by PV 
are rather easy to follow. PV reaches the central nervous system through the blood 
following replication in the lymphoid tissue of the pharynx and gut, including 
Peyer’s patches. From the blood the virus infects the meninges lining the spinal 
canal and then the anterior horn cells of the spinal cord during the first week of 
infection. These cells are destroyed within hours and if enough are affected, the 
innervated muscles become paralysed. In the worst cases poliovirus may affect the 
brainstem leading to respiratory failure and death. The portal entry of PV is 
generally thought to be the alimentary tract via the mouth. Shedding of virus occurs 
from the throat and in faeces and thus transmission of infection occurs independently 
of invasion of the nervous system, which occurs in only a minority of cases. The 
incubation period prior to the onset of the disease varies from 2 to 35 days (Minor et 
al., 1990; Oldstone, 1996; Melnick, 1990).
1.2.3 Structure
The precise three-dimensional structure of PV was elucidated by crystallographic 
studies (Hogle et al., 1985). It consists of an icosahedral protein shell (5:3:2) (fig. 
1.1) with an external diameter of ~300 Â that encapsidates a plus strand of RNA of 
roughly 7,500 bases. The virion shell is approximately 2.5 nm thick and has a 
relative molecular weight of 8 x 10 ,^ of which the RNA provides about 32 per cent 
and the protein 6 8  per cent by weight. The PV capsid is made up of 60 identical 
building units, each containing one copy of each of the four structural proteins, V Pl, 
VP2, VP3 and VP4, arranged with icosahedral symmetry. The folding pattern of
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VPl, VP2 and VP3 is similar, resulting in an eight-stranded antiparallel /7-barrel 
structure (Wetz & Habermehl, 1982; Hogle et a l, 1985). VP4 lies buried in close 
association with the RNA core whereas VPl, VP2 and VP3 are exposed at the 
surface of the virion with their N termini located at the interior face of the viral 
capsid. However, it has been shown that both VP4 and the N terminus of VPl are 
reversibly externalised at 37 °C (Li et a l, 1994). The capsid surface has a corrugated 
topography: there is a prominent star-shaped peak at the 5-fold axis of symmetry, 
surrounded by a deep depression (the “canyon”), and another protrusion (the 
“propeller”) at the 3-fold axis (Filman et a l, 1989).
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Figure 1.1 Electron micrograph of poliovirus and schematic representation 
of the icosahedral structure of poliovirus particles.
a) Whole vims particles (D antigen approximately 30nm in diameter (taken from 
(Minor et al., 1990)). b) Picomavirus particles are icosahedral structures with a 
triangular number T=3 packing of VPl, VP2, and VP3 on the surface of the particles 
(taken from (Rueckert, 1990)). VP4 is hurried deep inside that particle at the base of 
the protomer and is not an integral component of the framework making up the shell.
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1.2.4 Physical and chemical properties
The sedimentation coefficient of intact PV is 155-160S whilst that of the empty 
capsid is 70-80S. The buoyant density of the virion in caesium chloride gradients is 
1.34 g/cm^ (Mapoles et al., 1978). The low density of the virus implies that the 
virion is essentially impermeable. All enteroviruses are acid stable, surviving 
exposure to pH 3. This stability probably represents adaptation since these viruses 
must pass through the acidic conditions of the stomach in order to gain access to the 
gut. Enteroviruses are thermolabile. Their exposure to a temperature of 50 °C 
destroys them rapidly. However, in the presence of magnesium chloride, their 
inactivation at all environmental temperatures is inhibited (Wallis & Melnick, 1961; 
Melnick, 1990). The RNA within the virion is infectious and acts as mRNA for 
protein synthesis. Infectivity of the RNA is completely resistant to ribonuclease as 
long as the virion remains intact (Rueckert, 1990). A single break in the RNA, 
whether free or inside the virus particle, is sufficient to destroy infectivity.
1.2.5 Cytopathic effects
Following virus infection, changes in the morphology of the cells are detectable by 
visual and biochemical examination. These changes often referred to as the 
cytopathic effects (cpe) of a virus are observed early in PV infection. They possibly 
result from the production of viral proteins and nucleic acids, but mainly from 
alterations to the biosynthetic capabilities of the infected cells (Lenk & Penman, 
1979; Rueckert, 1990; Cann, 1997). The nuclei of the infected cells become 
crescent-shaped by 2.5 to 3 hours post-infection and are pushed aside to the cellular 
periphery. Chromatin is condensed in clumps that are attached to the nuclear
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membrane. This is accompanied by the appearance of numerous membranous 
vesicles in the cytoplasm, beginning first in the vicinity of the nucleus, that continue 
to proliferate for many hours until the entire cytoplasm is involved (Dales et a l, 
1965). These membranous vesicles are "tear-drop shaped", they are bound by double 
lipid bilayers and they have been found to contain markers from throughout the 
protein secretory pathway suggesting that they are derived from endoplasmic 
reticulum and secretory vesicles (Schlegel et a l, 1996). These vesicles are important 
in PV RNA replication as discussed in section 1.3.2. Changes in the permeability of 
the plasma membrane, associated with the spreading of the vesicles is also observed 
(Carrasco et a l, 1989; Holsey et a l, 1990). Also, the ribosomes become dispersed 
and no longer cluster in polyribosomes. Additionally, the appearance of the rough 
endoplasmic reticulum is altered. The vesicles bound by rough endoplasmic 
reticulum are considerably elongated and are located almost exclusively near the cell 
periphery. Leakage of the intracellular components, followed by shriveling of the 
entire cell are the cytopathic effects seen during the last stages of infection 
(Rueckert, 1990).
1.2.6 Membrane alterations
Changes in the membrane potential of the mitochondria in vitro were observed 
during the course of this project. Alterations of the plasma membrane of PV infected 
cells may be the cause of cpe and host cell death (Carrasco et a l, 1989). According 
to this hypothesis, virus products are targeted to the cell membrane and alter its 
function, thereby causing interference with several cellular processes and resulting in 
cell lysis and death. It is therefore important to review the membrane alterations 
caused by PV.
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Early in PV infection the entry of protein toxins such as a-sarcin is promoted. This 
phenomenon has been referred to as “early membrane permeabilisation” and it is 
specific to cells that contain the PV receptor (Carrasco, 1981; Almela et a l, 1991; 
Carrasco, 1995). Furthermore, this early permeabilisation does not always take place 
if the uncoating process of the PV is blocked; the introduction of PV growth 
inhibitors such as Ro-09-0410 specifically hinder both the uncoating step of PV and 
the early permeabilization to a-sarcin (Almela et a l, 1991).
During PV infection the permeability of cell membranes is profoundly changed 
allowing for enhanced permeability to cations and other compounds, a phenomenon 
referred to as “late membrane permeabilisation” because it requires viral gene 
expression (Carrasco et al., 1989). Additionally, increased passive diffusion 
(membrane leakiness) of compounds such as choline, nucleotides, and low molecular 
weight antibiotics also takes place (Contreras & Carrasco, 1979; Carrasco et al., 
1989; Irurzun et al., 1993; Carrasco, 1995).
Studies carried out on HeLa cells showed that as early as 2-3 hours post-infection the 
Na'^-K’*’ gradient of the cells collapses; the intracellular concentrations of Na^ 
increase whereas the contents decrease, hence the membrane potential is 
disrupted. These changes result partly from the inhibition ofNa^/R"^ ATPase activity 
and partly from the increased permeability of the plasma membrane (Nair, 1981; 
Schaefer et al., 1982; Lopez-Rivas et al., 1987). The concentrations of and Ca^ "^  
also change at approximately the same time that monovalent ion concentrations are 
affected. It has been shown that PV infection elevates the alkaline intracellular pH 
(pHi) and that this increase in pHi promotes viral replication (Holsey et a l,  1990;
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Holsey & Nair, 1993). However, the underlining mechanism whereby PV raises the 
pHi remains unknown though, it has been suggested that it may be due to the 
activation of a vacuolar-type (V) proton ATPase involving protein kinase C- 
mediated phosphorylation (Perez & Carrasco, 1993; Holsey & Nair, 1993). PV 
infection of HeLa cells also leads to an increase in the intracellular calcium 
concentration [Ca^^Ji (Irurzun et al., 1993). This increase is coincident with changes 
in the membrane permeability to monovalent cations and it reaches a 1 0 -fold by the 
fourth hour post- infection. Virus gene expression was found to be necessary for the 
increase of [Ca^ ' J^i; introduction of PV genome replication inhibitors (guanidine and 
Ro-09-0179) and protein synthesis inhibitors (cycloheximide) block increases in 
cytosolic calcium concentration (Irurzun et al., 1993). Recently, it was shown that 
the PV protein 2BC is responsible for the increase of cytosolic free calcium 
concentrations in HeLa cells infected with recombinant vaccinia viruses expressing 
2BC; the expression of 2BC increased [Ca^’^ Ji in a manner similar to that seen during 
PV infection (Aldabe et al., 1997). It is not known whether, 2BC promotes the entry 
of extracellular calcium alone, by a direct effect on the plasma membrane, or by an 
indirect effect on a cellular protein, such as a calcium channel.
The mechanism by which [Ca^^Ji is increased is not clear. According to Irurzun and 
co-workers, the extra calcium comes mainly from the extracellular medium but it is 
also possible that some of the increased intracellular calcium may come from the 
mobilisation of intracellular stores (Irurzun et al., 1993). Additionally, plasma 
membrane pore formation during infection simply allows extracellular calcium ions 
to pass through (Carrasco, 1995). Increases in inositol triphosphate (IP3) can also 
lead to the release of stored calcium from the endoplasmic reticulum (see below).
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The physical integrity of the membrane phospholipids is also altered during PV 
infection. The activity of phospholipase C is enhanced as early as the third hour after 
PV infection in HeLa cells (Guinea et a l, 1989; Irurzun et al., 1993). As a result of 
this increased activation, choline and phosphorylcholine are released into the 
medium and high amounts of IP3 are formed in the cytoplasm of the infected cells. 
The increase in IP3 is dependent on the multiplicity of infection used (Guinea et al., 
1989). PV gene expression is required to induce the increase in phospholipase C 
activity; inhibitors of PV gene expression, such as guanidine and cycloheximide, 
added at the beginning of infection block the choline release. However, not all 
phospholipases are enhanced by PV infection since the stimulation of phospholipase 
A2 by the calcium ionophore A23187 is hindered soon after PV infection (Guinea et 
al., 1989; Irurzun et al., 1993). The repercussions that these modifications of lipase 
activity may have for the cellular metabolism of the infected cells and for the 
functions of PV are not understood. PV RNA replication has been found to be 
physically associated with the phospholipid biosynthesis; the introduction of a 
phospholipid-synthesis inhibitor (cerulenin) after virus entry has been shown to 
selectively prevent the synthesis of PV proteins when added at the early stages of the 
viral protein synthesis (Guinea & Carrasco, 1990). It has been proposed that the 
increased intracellular calcium observed in PV infected cells may be due to the high 
levels of IP3 as a consequence of its binding to the IP3 receptor located in the 
endoplasmic reticulum (fig. 1 .2 ); however this suggestion has not yet been 
substantiated (Irurzun et al., 1993; Carrasco, 1995). Nevertheless, the presence of 
increased amounts of phospholipids in the plasma membrane destabilises the lipid 
bilayer and this may lead to the enhancement of membrane permeability observed in 
infected cells.
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Figure 1.2 Schematic representation of IP^  signal pathway.
The release of IP3 from phosphotidyl inositol 4,5-bisphosphate by phospholipase C 
(PLC) through the action of G-protein linked receptor or growth factor receptor 
agonists leads to the opening of a selective IPs-regulated channel located in the 
endoplasmic reticulum. This in turn causes the rapid discharge of the ER Ca^  ^pool 
into the cytosol followed by the opening of plasma membrane Ca^  ^ channels to 
regulate changes in cytosolic Ca^  ^ concentration in the form of Ca^  ^ oscillations 
(inset).
Although it has been shown that membrane permeabilisation requires viral gene 
expression, little is known about the PV proteins that may be responsible for this 
occurrence. The proteins that have been so far associated with membrane 
permeabilization are 2B, 2BC, 3A, and 3AB (Lama & Carrasco, 1992; Carrasco, 
1995; Doedens & Kirkegaard, 1995; Lama & Carrasco, 1996; Aldabe et al., 1996). 
When expressed in E.coli, the PV proteins 2B, 3A and 3AB strongly modify the
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bacterial cell membrane by increasing its permeability; hygromycin B (a 
nonpermeant translation inhibitor) strongly inhibits protein synthesis when bacteria 
expressing 2B, 3A or 3AB are exposed to the drug, normal bacteria are not inhibited. 
(Lama & Carrasco, 1992; Lama & Carrasco, 1996). Studies in mammalian cells 
obtained similar findings. Transient expression of either 2B or 2BC (and to a lesser 
extent 3A) in COS-1 and Hela cells caused an increase in the plasma membrane 
permeability to hygromycin B (Doedens & Kirkegaard, 1995; Aldabe et a l, 1996). 
Expression of these two PV proteins also increased the release of choline and uridine 
from preloaded cells (Aldabe et a l, 1996).
1.3 Molecular biology of the human poliovirus
1.3.1 The RNA genome
1.3.1.1 Structure
The PV genome is a single-stranded, positive-sense RNA molecule (messenger- 
active) of 7,433^ nucleotides. There is a 5' untranslated region (5' UTR), 740 
nucleotides long, which is important in translation and positive-sense RNA synthesis. 
This is followed by a single open reading frame, and a short 3' untranslated region (3' 
UTR), 72 nucleotides long, which regulates negative-sense RNA synthesis (figure 
1.3) (Kitamura et a l, 1981; Racaniello & Baltimore, 1981; Rueckert, 1990).
‘ For the Mahoney strain o f type 1 poliovirus (Racaniello & Baltimore, 1981)
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Figure 1.3 Genomic organisation of poliovirus (adapted from (Cuconati et a l,
1998)X
The untranslated regions are the most conserved parts of the genome. The 5' UTR 
contains a ‘clover-leaf secondary structure known as the 1RES (Internal Ribosome 
Entry Site) that is required for initiation of viral protein synthesis (Skinner et a l, 
1989; Andino et a l, 1990; Gebhard & Ehrenfeld, 1992; Jacobson et a l, 1993). 
Mutations of this region modify the translation of the PV RNA (Svitkin et a l, 1988; 
Haller et a l, 1996; Slobodskaya et a l, 1996). The 3' UTR has been less explored. It 
has been shown to contain an RNA pseudoknot structure that may be involved in 
RNA amplification (Jacobson et a l, 1993). Additionally, a phylogenetically 
conserved tRNA-like tertiary structure model for the 3'-terminal folding between all 
enteroviruses suggests that the 3' UTR structures are important to the life cycle of 
these viruses (Pilipenko et a l, 1992; Mirmomen et a l, 1997). However, polioviruses 
with partial deletions of their 3' UTRs have been recovered indicating that the 3' 
UTR structures may not be absolute requirements for RNA replication (Todd et a l, 
1997; Meredith et a l, 1999). Both ends of the genome are modified, the 5' end by a 
covalent attachment of a small, basic protein VPg (virion protein genome) (22 amino
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acids), the 3' end by genome encoded polyadenylation (polyA) (Yogo & Wimmer, 
1972; Dorsch-Hasler et a l, 1975; Cann, 1997; Cuconati et a l, 1998). VPg appears 
to be necessary for the initiation of PV RNA synthesis and it may also be important 
in other stages of PV replication (Morrow & Dasgupta, 1983; Reuer et a l, 1990). 
The function of the genetically encoded poly(A) remains unknown.
1.3.1.2 The polyprotein
Translation of the genome leads to the production of a 247 kDa polyprotein which is 
proteolytically processed by viral proteases both co- and post-translationally to 
generate individual virus proteins (figure 1.4) (Rueckert, 1990; Cann, 1997). The PV 
RNA genome contains all of the signals required for translation of the viral 
polyprotein and replication of the genome within the cytoplasm. The polyprotein is 
initially processed into three precursor polyproteins PI, P2 and P3. The PI precursor 
is co-translationally myristoylated and is cleaved into VPO, VP3 and VPl capsid 
proteins by the protease 3CD^^°. VPO is then autocatalytically cleaved to the VP2 
and VP4 capsid proteins, a step essential for infectivity (Wimmer et a l, 1993). P2 
and P3 are the precursors of non-structural proteins involved in the polyprotein 
maturation and RNA replication. Proteolytic processing of the P2 precursor yields 
three different end products, the cysteine protease 2A^ ™, 2B and 2C, and one long- 
lived precursor, 2BC (Rueckert, 1990; Wimmer et a l, 1993).
23
Chapter 1
Open Reading Frame
Translation
Polyprotein
PI P2 P3
lABCD 2ABC
VPO VP3 VPl
VP4 VP2 VP3 VPl
2A 2BC 3AB
3ABCD
3CD
Pro Pol
2B 2C 3A 3C 3D
VPg
Figure 1.4 Processing of the polyprotein (adapted from (Rueckert, 1990)).
catalyses the cleavage of the capsid precursor protein PI away from the nascent 
polypeptide at the junction between domains PI and P2 (Toyoda et a l, 1986). 2A^'° 
has been found to be involved in the shut-off of cellular mRNA translation, to be a 
translational activator of the polyprotein and to be implicated in the RNA replication 
(Davies et a l, 1991; Hambidge & Samow, 1992; Wimmer et a l, 1993; Yu et a l, 
1995; Lu et al., 1995). The functions and characteristics of 2BC and its cleavage 
products 2B and 2C are less well defined. 2BC is processed by 3C^ ™ to its cleaved 
products 2B and 2C. It has been shown that 2B, 2C and 2BC are contained within 
the replicative complex hence suggesting that they have a role in RNA replication
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(Bienz et a l, 1987; Bienz et a l, 1990; Bienz et a l, 1992; Bienz et a l, 1994). 
Additionally, 2C and 2BC but not 2B associate with membranes and induce vesicle 
formation (Cho et a l, 1994; Aldabe & Carrasco, 1995). It has been demonstrated 
that 2C is needed continually for viral RNA synthesis and it may have a function in 
determining the virion structure (Li & Baltimore, 1988; Baltera & Tershak, 1989; Li 
& Baltimore, 1990). 2C has also been shown to have ATPase and GTPase activities 
and to have an affinity for nucleic acids (Rodriguez & Carrasco, 1993; Mirzayan & 
Wimmer, 1994; Rodriguez & Carrasco, 1995). Studies on PV 2B mutants have 
indicated that 2B may be necessary for RNA amplification and also that 2B 
multimerisation, as well as 2BC and 2C multimerisation, is required for the 
occurrence of viral replication (Johnson & Samow, 1991; Cuconati et a l, 1998). 2B 
has been shown to inhibit the secretion of cellular proteins, and to block the 
permeabilisation of the plasma membrane and the disassembly of the Golgi apparatus 
(Doedens & Kirkegaard, 1995; Aldabe et a l, 1996; Sandoval & Carrasco, 1997).
The P3 precursor is generated by cleavage at the amino terminus of the 3A-coding 
region followed by rapid processing to yield the relatively stable intermediates 3AB 
and the protease 3CD^™. Slow processing of the two intermediates generates the four 
cleavage end products 3A, the genome-linked protein VPg (also known as 3B), the 
protease 3C^ °^ and the RNA-dependent RNA polymerase 3D^ °^  (Rueckert, 1990; 
Wimmer et a l, 1993). 3AB is a cytoplasmic membrane-associated protein that serves 
as a precursor for VPg and 3A (Tagekami et a l, 1983; Richards & Ehrenfeld, 1990; 
Lama et a l, 1994). Its role in the PV replication cycle remains largely unknown, but 
purified 3AB greatly stimulates the activity of 3D^ °^  in vitro (Lama et a l,  1994). 
Additionally, 3AB induces cell membrane permeability (Lama & Carrasco, 1996).
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3A is essential for RNA replication and it has been found to inhibit cellular protein 
secretion (Doedens & Kirkegaard, 1995; Xiang et al., 1995). VPg is necessary for 
the initiation of RNA replication (Takeda et al., 1986; Reuer et al., 1990). 3AB and 
to a lesser extent 3B are necessary for the stimulation of the autocleavage of 3CD^™ 
to 3 C ^  and 3D^ °* (Molla et a l, 1994). 3C^ ™ and its precursor 3CD^™ mediate most 
of the cleavages in the polyprotein but not the cleavage of VPO to VP2 and VP4. 
Additionally, 3C^ ™ irreversibly inhibits cellular translation and transcription (Clark et 
al., 1991; Clark et al., 1993; Yalamanchili et al., 1996). 3D^ °^  catalyses chain 
elongation of viral RNA in virus-infected cells (Flanegan & Van Dyke, 1979; Young 
et al., 1985). In addition, the formation of a complex between 3D^ °^  and 3AB 
stimulates polymerase activity above that of 3D^ °^  alone (Paul et al., 1994; Plotch & 
Palant, 1995).
1.3.2 Replication and the replication complex
The time required for a complete multiplication cycle, from infection to completion 
of virus assembly, ranges from 5 to 10 hours. Approximately 10"^ -10^  infectious 
virus particles are produced in one infected cell which is finally destroyed allowing 
the viruses to be released to infect new target cells (Rueckert, 1990; Hyypia et al., 
1997). To initiate infection the virus is attached to the cellular receptor (CD 155 also 
known as PVR), a membrane-anchored glycoprotein (Mendelsohn et al., 1989). 
Capsid structural reorganisation is brought about by the interaction with the cellular 
receptor(s) leading to exposure of the internal VP4 polypeptide and, subsequently, 
uncoating of the RNA genome (Rueckert, 1990; Richards & Ehrenfeld, 1990; 
Racaniello, 1996).
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Many details concerning the mechanism of PV replication in vivo remain unknown. 
PV RNA replication occurs in the cytoplasm of infected cells by using both newly 
translated viral proteins and various host components. The replication occurs in the 
replication complex (RC) found associated with smooth membranes and the 
cytoskeleton (Caliguiri & Tamm, 1969; Lenk & Penman, 1979; Bienz et a l,  1990; 
Rueckert, 1990; Bienz et al., 1994). carries out the replication of the RNA
genome with the aid of other viral and cell host factors. The RNA is replicated in 
two steps. First, genomic RNA of the infecting virus is copied into a minus strand, 
which leads to the formation of the partially double stranded replicative form (RF) 
(Takeda et al., 1986). From the replicative form a partially double stranded 
replicative intermediate (RJ) is formed and subsequently progeny RNA strands of 
positive polarity are produced (Butterworth et al., 1976; Btchison & Ehrenfeld, 
1981). The (+) RNA is then translated and as the concentration of the protein 
increases, an increasing fraction of (+) RNA is packaged into virions. Formation of 
infective virions is accompanied by a "maturation cleavage" in which most of the 
VPO chains are cleaved to form the "mature" four structural proteins VP 1-4 
(Rueckert, 1990). Completed virus particles are ultimately released by infection- 
mediated disintegration of the host cell.
The RCs are found in the centre of rosettes formed by many virus-induced vesicles 
and they remain associated with the outer surfaces of these vesicles (Bienz et al., 
1983; Bienz et al., 1987; Bienz et al., 1992). The RC contains a tightly packed 
membrane system itself that encloses the RJ with its nascent (+) RNA (fig. 1.5) 
(Bienz et al., 1992). This system interacts with the surrounding virus-induced 
vesicles in the last steps of completion of mature progeny (+) RNA to release the
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completed 36S RNA from the RJ and from the RC to the surface of the rosettes. 
Hence, only mature progeny (+) RNA is found on the surface of the rosette, whereas 
the RNA-synthesising machinery is enclosed and protected in the interior (Bienz et 
aA ,1992).
Recent studies have shown that the rosettes can be reversibly dissociated into their 
components, the virus-induced vesicles that are capable of initiation and elongation 
of (+) RNA on their own (Egger et al., 1996). Structural analysis showed that the 
vesicles have tubular protrusions with parts of the RC attached to them and upon 
reassociation, the protrusions extend inwards into the RC in the centre of the rosette. 
Immunoprécipitation showed that the vesicles carry sets of nonstuctural (2C, 2BC, 
3D, and 3 CD) and capsid proteins (14S pentamers) as well as a RJ that was found to 
be attached to the surface of the rosettes. During the course of this study it was also 
found that the membranes of the virus-induced vesicles are not necessary for 
elongation of viral RNA but are required for initiation of viral (+) RNA synthesis 
(Egger er a/., 1996).
The intracellular formation of these vesicles has been attributed to the viral protein 
2BC (Bienz et al., 1983; Aldabe & Carrasco, 1995; Cho et al., 1994; Barco & 
Carrasco, 1995). The P2 proteins 2B, 2BC, and 2C are contained exclusively within 
the RC and the vesicular membranes and expression of the recombinant P2 proteins 
2BC and/or 2C in cultured mammalian and yeast cells has confirmed the vesicle- 
inducing and membrane-altering properties of these proteins (Bienz et al., 1987; 
Aldabe & Carrasco, 1995; Cho et al., 1994; Barco & Carrasco, 1995). However, the 
complete role of the P2 genomic proteins in replication is not understood entirely.
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Figure 1.5 Electron micrograph of a poliovirus replication complex (RC) 
surrounded by virus-induced vesicles (V). Bar, 100 nm. Taken from (Bienz et al,  
1992).
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1.4 Mitochondria
Mitochondria are bacteria-sized organelles, found in the cytoplasm of almost all 
types of eukaryotic cells, and their main (but not only) function is the production of 
most of the cell’s energy.
Mitochondria are thought to be derived from prokaryotic microorganisms, which 
evolved a symbiotic relationship with their eukaryotic hosts (Gray et al., 1999; 
Duchen, 1999; Wallace & Starkov, 2000). As a consequence of that origin, 
mitochondria still own an autonomously replicating and expressing genome of about
16.6 kb, the mitochondrial DNA (mtDNA). Studies of mtDNA and its expression 
have further accredited the eubacterial roots of this genome (Gray & Doolittle, 1982; 
Gray et al., 1998). Furthermore, elucidation of different mitochondrial genomes has 
enabled scientists to trace the evolutionary ascendants of mitochondria to a single 
ancestor, the prokaryote Agrobacterium tumefaciens, related to the a  subdivision of 
the so-called purple bacteria (also known as Proteobacteria) (Yang et al., 1985). The 
present boundaries of the evolutionary divide between mitochondria and their 
eubacterial relatives are currently inscribed by the published complete sequences of 
the obligate intracellular proteobacterium Rickettsia prowazekii (R. prowazekii) (the 
causative of epidemic louse-borne typhus) (Andersson et al., 1998) and the 
freshwater protozoon Reclimonas americana {R. americana) (Lang et al., 1997). 
Phylogenetic analysis indicates that R. prowazekii is more closely related to 
mitochondria than is any other microbe studied so far, thus identifying its genome as 
the most mitochondria-like eubacterial one (Andersson et a l, 1998; Yang et al., 
1985; Gray et al., 1989). R. americana mtDNA more closely resembles the ancestral 
mitochondrial-like eubacterial genome than any other mtDNA investigated so far, as
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exhibited by the eubacterial characteristics of the structure and expression of its 
genome (Lang et a l, 1997).
The R. prowazekii genome sequence has enforced the association to the 
mitochondrial genome. However, the search for mitochondrial genomes even more 
ancestral than that of R. americana continues in an effort to uncover even larger, 
more gene-rich mtDNAs. In addition, mitochondrial protein-coding sequences and 
genome data may ultimately aid the elucidation of the phylogenetic relationships that 
nuclear gene sequences are currently unable to resolve.
1.4.1 Structure
Mitochondria are intracellular organelles, varying in both shape and size. They may 
be spherical or elongated, or even branched with a typical size between 0 .7 -1  pm 
(Alberts et ah, 1994; Nicholls & Ferguson, 1997). The abundance of mitochondria 
varies among cell types, for example, thymus lymphocytes contain 6 - 1 2  organelles, 
whereas typical fibroblasts contain a massive and dynamically fluctuating network 
composed of an indefinable number of single interconnected mitochondria (Wallace 
& Starkov, 2000).
Regardless of the cell type and despite the wide variety in number and morphology, 
all mitochondria share several fundamental structural properties (Alberts et ah, 1994; 
Nicholls & Ferguson, 1997; Wallace & Starkov, 2000). The appearance of a section 
through a typical mitochondrion is shown in figure 1 .6 .
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Figure 1.6 The general structure of a mitochondrion. Taken from (Nicholls & 
Ferguson, 1997).
Each mitochondrion is bound by two highly specialised lipid bilayer membranes. 
Together they create two separate mitochondrial compartments: the internal water- 
containing matrix space and a much narrower intermembrane space. The matrix 
contains hundreds of enzymes including those of the tricarboxylic acid cycle and the 
(3-oxidation pathway. It also contains several copies of the mtDNA genome, transfer 
RNAs, special mitochondrial ribosomes and various enzymes required for expression 
of the mitochondrial genes. The outer membrane is rich in cholesterol and contains 
several proteins termed porins, which act as non-specific pores for ions and solutes 
up to 14 kDa. It also contains embedded or attached enzymes that interface the 
mitochondrion with the rest of the cellular metabolic network. The inner membrane 
is folded into numerous cristae thus increasing its total surface area. It is not freely 
permeable to metabolites and ions but it contains specific transport proteins, which 
regulate the passage of selected metabolites into and out of the matrix. It also
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contains proteins that carry out the oxidation reactions of the respiratory chain and 
the enzyme complex ATP synthase, which makes ATP in the matrix.
1.4.2 Functions of mitochondria
Mitochondria are primarily ATP generators and the principal form of energy 
generated in mitochondria is the so-called electrochemical proton gradient that is 
produced by the three of the four respiratory enzyme complexes of the mitochondrial 
respiratory chain (or electron transport chain), found on the inner membrane of the 
mitochondria (fig 1.7) (Mitchell & Moyle, 1967; Nicholls & Ferguson, 1997). This 
gradient supplies the energy required to produce ATP, and to support other activities 
of the mitochondria, such as the electrophoretic or protonophoric transport of ions, 
metabolic substrates, and proteins destined for the mitochondrial matrix. ATP is 
required to drive the majority of energy-requiring reactions such as phosphorylation 
reactions that modulate a number of essential cellular processes, it may be stored as a 
(neuro)transmitter, and it controls the activity of several classes of ion channel 
including the ATP-sensitive channel, the calcium release channel of sarcoplasmic 
reticulum and voltage-gated calcium channels (Duchen, 1999).
The mitochondrial respiratory chain comprises a series of reduction/oxidation 
reactions within complexes I, II, III, and IV (fig. 1.7). These reactions are linked by 
ubiquinone and cytochrome c (Nicholls & Ferguson, 1997; Salway, 1999; Saraste, 
1999). Ubiquinone, which accepts electrons and protons as it is reduced to 
ubiquinol, shuttles fi-om both complexes I and II, to complex III. Similarly, 
cytochrome c shuttles electons from complex III to complex IV.
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Figure 1.7 The respiratory chain showing the flow of electrons from NADH 
to oxygen and the extrusion of protons by complexes I, III and IV.
The synthesis of ATP is the result of two processes, electron transport and oxidative 
phosphorylation and proton transport. Electron transport involves the oxidation from 
NADH + H^, or FADH2 with transport of the electrons through the mitochondrial 
respiratory chain until they are donated to molecular oxygen, which is subsequently 
reduced to water. This electron transport, according to Mitchell’s chemiosmotic 
theory, drives proton pumps in complexes I, III and IV by a mechanism still not fully 
understood (Mitchell & Moyle, 1967). Positively charged protons, but not any 
associated negatively charged anions, are pumped out of the mitochondrial matrix to 
the cytosol (intermembrane space). Proton pumping is ultimately coupled to electron 
flow so that there is no respiration without proton pumping and vice versa. As a 
result, the matrix side of the membrane becomes negatively charged, whilst the 
extruded protons ensure that its opposite side becomes positively charged thus 
making the inner mitochondrial membrane anisotropic. The difference in 
electrochemical potential across the membrane is about 150-250 mV (mitochondrial
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membrane potential) and it provides the energy for ATP synthesis when the protons 
return to the matrix through the Fo proton channel and the Fi ATP synthase. At 
present, it is the general consensus that three protons are needed to form one ATP 
molecule and an additional proton is needed to translocate it to the cytosol. Key 
membrane protein components of the mitochondrial respiratory enzymes and the 
ATP synthase are encoded by genes in the mitochondrial DNA, and others are 
encoded in the nucleus. The fundamental question of how ATP is synthesized by 
FiFoATPase remains unanswered. Studies have led to the theory that a central 
structure inside the FiATPase may be present that rotates, probably due to 
protonmotive force, and could result in the translocation of four protons per one ATP 
molecule synthesized (Sabbert et a l, 1996; Noji, 1998; Yasude et a l, 1998; Saraste, 
1999). The determination of the three-dimensional structure of the entire ATP 
synthase is necessary for a better understanding of the mechanism of ATP synthesis.
Mitochondria also take up calcium (Ca^^), thus contributing to the cellular 
homeostasis, and are functionally tightly integrated into mechanisms of cellular 
calcium signaling. Mitochondrial is regulated through trasport mechanisms, for 
both Ca^  ^ uptake and efflux, of the inner membrane (Gunter & Pfeiffer, 1990). 
Uptake of Ca^ "^  is through the potential-dependent uniporter, a mechanism driven by 
the mitochondrial membrane potential. Three possible pumping mechanisms for the 
efflux of Ca^  ^have so far been identified: a 2 NaVCa^^ exchanger which is linked to 
electron transport chain proton pumping via Na' /^H'  ^ exchange; a sodium ion 
independent mechanism, known to be an electroneutral Ca^V2H'*’ exchanger (Puskin 
et a l, 1976; Haworth & Hunter, 1979; Bowser et a l, 1998) and a process known as 
the mitochondrial transition pore (MTP) which may be due to a large proteinaceous
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pore (further discussed in chapter 5). The kinetics of mitochondrial Ca^  ^uptake and 
release appear to differ between cell types which may reflect differences in 
intracellular Na^ availability for the mitochondrial NaVCa^ exchanger (Duchen,
1999).
Mitochondria are also important in glucose homeostasis. Mitochondrial respiration 
is stimulated by the delivery of substrate in pancreatic y0 -cells and glucose-sensing 
neurons of the hypothalamus which, results in the closing of certain channels in 
the plasmalemma and the subsequent opening of voltage-gated Ca^^ channels. This 
promotes insulin secretion, which in turn lowers plasma glucose (Duchen et ah, 
1993; Duchen, 1999). Furthermore, the supply of glucose to the yg-cells, increases 
substrate supply to the tricarboxylic acid cycle, increases the provision of NADH and 
FADH2 to the respiratory chain, and increases respiratory rate which then leads to 
increased ATP production.
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1.5 Research objectives
As described in the previous sections enteroviruses have a tropism for muscle cells 
and have been linked to the development of CFS and post-polio fatigue. Muscle 
fatigue made worse by exercise is one of the major symptoms in CFS. Abnormalities 
in cellular energy levels suggestive of an impairment of mitochondrial function have 
been reported following virus infection. A mitochondrial disorder precipitated by a 
virus infection has been suggested as the cause for the unexplained fatigue in CFS. 
In addition, the PV non-structural proteins 2B and 2BC could possibly be involved in 
the mitochondrial abnormalities since they have been extensively associated with 
changes in membrane permeability and proliferation (as reviewed in sections 1 .2 . 6  
and 1.3.2)
The main objective of this project was to establish whether mitochondrial function 
was affected by PV infection and to identify the PV proteins involved in this effect. 
This should lead to improved understanding of the muscle fatigue observed in 
patients with CFS.
Specifically, mitochondrial function was investigated in different mammalian cell 
lines infected with poliovirus, and the role of the non-structural poliovirus proteins 
2B and 2BC was investigated:
1. To assess the effect of PV infection on cellular and mitochondrial respiration.
2 . If mitochondrial respiration was blocked to investigate the specific site of the 
blockage.
3. To examine the mitochondrial membrane potential of PV infected cells.
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4. To examine the consequences of PV infection on mitochondrial energy 
production.
5. To express the proteins 2B and 2BC in mammalian in order to investigate 
their possible effect on normal mitochondrial activity.
6. If time permits, raise antibodies specific for these proteins in order to 
investigate their intracellular localisation.
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MATERIALS AND METHODS 
2.1 Materials
2.1.1 Suppliers
Amersham International pic, Buckinghamshire, UK 
dATP; conjugated anti-goat IgG-HRP antibodies.
Bio-Rad Laboratories Ltd, UK
Kaleidoscope pre-stained standards; acrylamide and bis-acrylamide; Whatman 3MM 
filter paper.
Biotecx Laboratories, Inc, USA.
RNAzol B.
Boehringer Mannheim Ltd, Mannheim, Germany
CIP; lOx CIP buffer; restriction enzymes and their respective lOx buffers.
British Drug House (BDH) Ltd, UK
Ammonium acetate; butan-2-ol; liquid paraffin; acetone; isopropanol; polyethylene 
glycol; ammonia.
Fischer Scientific International Co., UK
Ethyl alcohol; formaldehyde; methanol; potassium acetate; sodium hydroxide; 
hydrochloric acid; acetic acid (glacial); formaldehyde; PCA; acetonitrile.
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Gibco-BRL, Paisley, Scotland
GMEM; RPMI-1640; DMEM; PCS; gentamycin; penicillin/streptomycin; versene; 
trypsine; sodium bicarbonate; glutamine; formamide; lipofectin®; Opti-MEM® I 
Reduced Serum Medium; PBS; electrophoresis grade agarose; RNAseIn; 
bacteriophage lambda DNA; M-MLV RT.
Invitrogen
RNase ZAP, S.N.A.P.™ miniprep kit.
Millipore UK
Immobilon™-P nitrocellulose membrane.
Molecular Probes Europe BV  
TMRE; Hoechst 33342.
National Diagnostics UK 
HRPL substrates A and B.
Oxoid Ltd, Basingstoke, UK
Bacto agar; bacto tryptone; bacto yeast extract; nutrient broth; PBS tablets.
Pharmacia Biotech, UK
DEPC treated water; dNTPs; RNase H; pGEX-4T-2 and pGEX-4T-3 gene fusion 
vectors; Glutathione Sepharose 4B beads; glutathione; goat anti-GST antibody.
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Promega Corp. UK
Wizard™ clean-up system; Klenow fragment; T4 DNA polymerase; lOx T4 DNA 
polymerase buffer; T4 DNA ligase; lOx T4 DNA ligase buffer;.
QiagenLtd. UK 
QIAquick gel extraction kit.
Sigma-Aldrich Chemical Co. Ltd, UK
Acrylamide; ammonium persulphate; ampicillin; BSA; kenacid blue; DTT; ethidium 
bromide; IPTG; X-gal; TBMED; protein molecular weight markers; salmon sperm 
DNA; 2-mercaptoethanol; DMSO; trypan blue dye; crystal violet; SDS; saponin; 
NaCl; Hepes; ESIT; rotenone; succinic acid; SDS; malonate; chloroform; Tris-base; 
EDTA; guanidine thiocyanate; MgCl2; CaCl2; KCl; boric acid; glycerol; MOPS; 
polyvinyl pyrrolidone; frcoll; glycine; bromophenol blue; 0.4% (w/v) trypan blue; 
ATP; Tween 20; potassium ferricyanide; potassium ferrocyanide; potassium 
phosphate; ADP; AMP; adenosine; inosine.
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2.1.2 Solutions and buffers
2,1.2.1 Microbial growth medium 
SOB medium
Bacto tryptone 20g
Bacto yeast extract 5g
NaCl 0.5g
250mMKCl 10ml
Distilled water to 11. The pH was adjusted to 7.0 with NaOH. After sterilisation by 
autoclaving 5ml of sterile 2M MgCl] were added.
2xYT medium
Bacto tryptone 16g
Bacto yeast extract lOg
NaCl 5g
Distilled water to 11, sterilise by autoclaving.
2xYT medium used for inoculations contained ampicillin (50pg/ml).
Agar plates
1.2g of Bacto agar were added to 100ml 2xYT medium and boiled to dissolve. The 
agar was then cooled to 50 ^C before adding ampicillin and if  required X-Gal and 
IPTG as follows: ampicillin stock solution (25mg/ml) was made in water and added 
of a final concentration of 50pg/ml; 2% X-Gal stock solution was made in dimethyl 
formamide and used at 1:200; O.IM IPTG was dissolved in water and used at 1:400.
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2.1.2.1 Buffers used in molecular cloning 
5x first strand buffer
Tris-HCl, pH 8.3
KCl
MgClz
250mM
375mM
15mM
lOx second strand buffer
Tris-HCl, pH 8.3 188mM
KCl 906mM
MgCli 46mM
DTT 37.5mM
T4 DNA polymerase buffer
Tris-HCl, pH 7.9 0.33mM
Potassium acetate 0.66mM
MgClz O.IM
DTT 5mM
lOx ligation buffer
Tris-HCl, pH 7.6
MgCli
DTT
Spermidine
BSA
660mM
lOOmM
150mM
lOmM
2mg/ml
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2.1.2.3 Agarose gel DNA electrophoresis buffers 
lOxTBE running buffer
Tris base 107.8g
Boric acid 55g
EDTA 9.3g
Distilled water to 11, sterilised by autoclave.
2xTBE sample buffer
lOxTBE running buffer 4ml
Glycerol 4ml
Distilled water 12ml
Bromophenol blue and xylene cyanol FF dyes were added to this buffer until its 
colour became an intense purple/blue.
2.1.2.4 Northern blotting solutions 
lOxMOPS buffer
MOPS 0.2M
Sodium acetate 0.05M
EDTA O.OIM
pH 7.0 with NaOH 
Sample buffer
Formamide 0.5ml
lOxMOPS 0.1ml
Formaldehyde 0.15ml
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Pre-hybridisation solution
20xSSC 15ml
200mM EDTA 25ml
lOOx Denhadt’s solution 2.5ml
20% SDS 1.25ml
Carrier DNA 0.5ml
Distilled water 28.25ml
Pre-hybridisation solution was stored at 4 ®C, and warmed to re-dissolve.
lOOx Denhardt’s solution- 5 g bSA; 5g polyvinyl pyrrolidone; 5g ficoll; water to 
250ml.
Carrier DNA: lOmg/ml salmon sperm DNA in distilled water, boiled and sheared. 
Hybridisation wash solution: 2 % SSC plus 0.1% SDS.
OLB solution: 250mM Tris-HCl, pH8.5; 25mM 2-mercaptoethanol; OlmM each of 
dCTP, dGTP, dTTP; IM Hepes, pH 6.6.
Stop/quench solution:
4M NaCl 50 pi
IM Tris, pH 7.5 200pl
200mM EDTA lOOpl
20% SDS 125pl
Distilled water 9.50pl
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2.1.2,5 SDS-PAGE solutions
Resolving buffer: 0.75M Tris, pH 8.8 with concentrated HCl 
Stacking buffer: 0.25M Tris, pH 6.8 with concentrated HCl
Acrylamide:bis-acrylamide: 4 q% stock by mixing 40g acrylamide with 1.08g bis- 
acrylamide and made to 100ml with distilled water.
Running buffer
Tris 3.02g
Glycine 14.44g
20% SDS 5ml
Distilled water to 11, pH 8.2
Ix loading dye
Stacking buffer 2.5ml
20% SDS 1ml
Glycerol 2g
2-mercaptoethanol 0.25ml
1% bromophenol blue 0.05ml
Distilled water to 10 ml.
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10% resolving gel
Distilled water 4.6ml
Resolving buffer 10ml
Acrylamiderbis-acrylamide 3.8ml
20% SDS 0.1ml
Ammonium persulfate 0.6ml
TEMED 12pl
4% stacking gel
water 3.75ml
Stacking buffer 5ml
Acrylamide:bis-acrylamide 1ml
20% SDS 50pl
Ammonium persulfate 0.25ml
TEMED lOpl
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2.2 Mammalian cell culture
2.2.1 Cell lines
Three mammalian cell lines were used during the course of this study:
Vero cells
African green monkey kidney anchorage-dependent fibroblasts that grow 
continuously in culture. These cells are susceptible to a wide range of viruses 
including poliovirus and reoviruses.
The cells were grown in Glasgow’s modified Eagles basal medium (GMEM), 
supplemented with 10% (v/v) heat inactivated foetal calf serum (ECS), 2mM 
glutamine, 1% (v/v) gentamycin, 1% (v/v) penicillin/streptomycin and 2.7% (v/v) 
sodium bicarbonate, pH 7.0. Incubation of the cells was carried out at 37 °C in a 
humidified atmosphere of 5% CO2 in air. Once the cells formed a confluent 
monolayer, they were subcultured in the following manner: the medium was 
aspirated and the cells were detached by the addition of versene containing 10% (v/v) 
trypsin. Pre-warmed (37 °C) GMEM was added to the detached cells and they were 
centrifuged for 5 min at 1,500 rpm. The supernatant was then discarded and the cells 
were split 1:3 in fresh GMEM and added to new tissue culture flasks containing an 
appropriate volume of fresh GMEM.
COS-1 cells
Afirican green monkey kidney CV-1 cells (fibroblasts) transformed with SV40 DNA. 
These also grow continuously in culture and they are possible hosts for the 
propagation of recombinant SV40 virus.
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The cells were grown in DMEM, supplemented with 10% (v/v) heat inactivated FCS, 
2mM glutamine, 5% (v/v) gentamycin, 1% (v/v) penicillin/streptomycin and 5% 
(v/v) sodium bicarbonate, pH 7.0. Incubation of the cells was carried out at 37 °C in 
a humidified atmosphere of 5% CO2 in air. Once the cells formed a confluent 
monolayer they were subcultured in the same manner used for Vero cells.
T47D cell
A continuous human breast carcinoma epithelial cell line carrying receptors to a 
variety of steroids.
The cells were grown in RPMI 1640 medium; supplemented with 10% (v/v) heat 
inactivated FCS, 2mM glutamine, 1% (v/v) gentamycin, 1% (v/v)
penicillin/streptomycin and 2.7% (v/v) sodium bicarbonate, pH 7.0. Incubation of the 
cells was carried out at 37 °C in a humidified atmosphere of 5% CO2 in air. Cell 
growth was slow and it required addition of fresh media for the cells to reach 
confluency. Once the cells formed a confluent monolayer they were subcultured in 
the same manner used for Vero cells.
2.2.2 Freezing of cell lines
Confluent cells were detached using versene/trypsin and centrifuged as described in 
section 2.1.1. The cells were then resuspended in sufficient, pre-warmed (37 °C), 
medium (80% (v/v) normal growth medium, 10% (v/v) heat inactivated FCS, 10% 
(v/v) dimethyl sulphoxide (DMSO)) to give a final cell density of 4-6 x 10  ^cells/ml.
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1 ml aliquots of the resuspended cells were pipetted into cryotubes and frozen slowly 
to -70 °C overnight before storage in liquid nitrogen.
Cells were recovered after storage, by thawing a frozen aliquot was thawed rapidly in 
a 37 °C waterbath. The cell suspension was then diluted with 10 ml of the respective 
growth medium (pre-warmed to 37° C) and centrifuged at 1,500 rpm for 5 min to 
remove the DMSO. The cell pellet was resuspended in 5 ml of growth medium, 
transferred to a small tissue culture flask and incubated at 37° C in a humidified 
atmosphere of 5% CO2 in air. The medium was changed 24hrs later to ensure the 
complete removal of the DMSO. The cells were then subcultured as described in 
section 2.1.1.
2.2.3 Cell counting
Cell density was determined by adding lOOpl 0.4% trypan blue dye (w/v) in PBS to a 
lOOpl cell suspension. Counting was carried out by introducing a sample of the 
stained cell suspension into a Neubauer Heamocytometer grid.
2.3 Viral culture techniques
2.3.1 Virus strain and growth
During the course of this study the virus used was Mahoney strain of type 1 
poliovirus (designated as polio I).
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Polio I was propagated in Vero cells. The cells were inoculated with virus in 
medium identical to the growth medium (GMEM) except that it was supplemented 
with 2% heat inactivated FCS instead of 10%. The inoculated cells were incubated 
overnight at 37° C in a humidified atmosphere of 5% CO2 in air. After 72 hrs 
incubation, virus propagation was complete and the medium harvested. Aliquots of 
the virus-containing medium were frozen at -70° C, 1 ml was kept separate for the 
determination of virus titres.
2.3.2 Virus titration (plaque assay)
35 mm wells were seeded with 5 x 10  ^Vero cells in 2 ml normal growth GMEM and 
incubated at 37 °C in a humidified atmosphere of 5% CO2 in air until confluent. The 
virus stock was diluted 10'^  -10'^ in PBS. The incubation medium was then replaced 
with 0.4ml of virus dilution per well, medium only was used as control. The virus 
was then allowed to adsorb by standing the dishes for 1 hr at 37 °C in a humidified 
atmosphere of 5% CO2 in air, with gentle rocking at 10 min intervals. The wells 
were then overlayed with 2ml of 0.5% agar (kept at 42 °C) in GMEM (double 
strength with 2% heat inactivated FCS) and allowed to set before being incubated for 
2-3 days at 37 °C in a humidified atmosphere of 5% CO2 in air. The incubation was 
followed by a 10 minutes fixation of the cells with 2ml saline containing 10% 
formaline. The agar layer was flushed away with water and the wells were stained 
with 0.5ml crystal violet stain (0.1% (w/v) crystal violet in 20% (v/v) ethyl alcohol) 
for 15 - 30 min. Excess stain was then washed away, and the plaques were counted. 
The viral titre was calculated in plaque-forming units (pfu) per cell.
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2.3.3 Virus infection of cell lines
Monolayer cultures were grown to confluence or near confluence by incubation for 
18-24 hrs in normal growth medium. The cultures were then infected with polio I 
(titrated in Vero cells) at a multiplicity of infection of 15 pfu/cell in growth medium 
containing 2% (v/v) heat inactivated FCS instead of 10%. The virus was allowed to 
adsorb by standing the cultures for 1 hr at 37 °C in a humidified atmosphere of 5% 
CO2 in air, with gentle rocking at 10 min intervals. The inoculum was then removed, 
monolayers were washed using PBS and fresh normal growth medium was added. 
Finally, the cultures were incubated at 37 °C in a humidified atmosphere of 5% CO2 
to allow the virus to grow as required. Mock-infection of cultures was carried out in 
a similar fashion but in the absence of virus.
2.4 Measurement of mitochondrial membrane potential with  
tetramethylrhodamine ethyl ester
Mammalian cells were grown in 6-well plates on round glass coverslips and infected 
as described in section 2.3.3. Mock-infected cell cultures were similarly prepared. 
At 0, 2, 4, 6 and 8 hours post-infection, coverslips were washed with medium and 
incubated for 15 minutes at 37 °C with 1 ml normal growth medium supplemented 
with 0.5pM TMRE. Cultures were then transferred to a Zeiss POC chamber 
mounted on a Zeiss Axiovert 135 fluorescence microscope connected to a 
microcomputer imaging device (MCID) digitised video analysis system equipped 
with a DAGE-72 CCD camera (excitation wavelength, 520nm, emmision 
wavelength, 560nm). TMRE fluorescent images were recorded and digitised for 
analysis of pixel intensity using the MCID software.
53
Chapter 2
2.5 Measurement of oxygen consumption
2.5.1 Measurement of total oxygen consumption
Confluent monolayers of COS-1 or T47D cells were infected as described in section
2.3.3. Cells were then incubated in either DMEM (COS-1 cells) or RPMI-1640 
(T47D cells) medium (2% FCS). The cells were detached from flasks at different 
time points post infection by gentle scraping, and resuspended in 2 ml PBS (COS-1 
cells, 8x10^  cells/ml; T47D cells, 3.3 x 10  ^ cells/ml). The resuspended cells were 
then transferred into a thermal-jacketed Clark-type oxygen electrode chamber 
(calibrated using sodium dithionite) maintained at 37 °C, and the total cellular 
oxygen consumption was measured.
2.5.2 Measurement of mitochondrial electron chain activity
Mitochondrial respiratory chain activity was measured in cells resuspended in a salt 
solution, that mimics the intracellular environment (lOOmM KCl, 20mM NaCl, 
0.5mM MgCl], 25mM Hepes, pH 7.2). 8x10^ cells/ml in 2 ml were transferred into 
the chamber of a the Clark-type oxygen electrode, and permeabilised by the addition 
of saponin to 40pg/ml. Saponins are a group of naturally occurring plant glycosides 
able of removing the barrier function of the plasma membrane without disturbing the 
mitochondrial function of cells (Kass et a l, 1993). The efficiency of this 
concentration of saponin to permeabilise the plasma membrane was monitored. 
Analysis by trypan blue (0.2% (w/v)) exclusion showed that 90-95% of the cells 
were permeabilised. Substrates and inhibitors of mitochondrial respiration were then 
added as described in section 3.2.
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2.6 Assay of succinate dehydrogenase activity
Confluent cell monolayers were infected or mock-infected as described in section
2.3.3. Following harvesting by gentle scraping, the cells were washed, resuspended 
in ice-cold PBS buffer and sonicated on ice using a Soniprep 150 probe sonicator (3 
X 5sec bursts; 10pm). The cell lysates were assayed for succinate dehydrogenase 
activity by measuring the succinate-stimulated reduction of P-iodonitrotetrazolium 
violet (INT) to its formazan derivative in an assay mixture (total volume of 0.7ml) 
containing cell lysate (firom 7 x 10"^  cells), INT (0.57mg/ml), rotenone (7pg/ml) and 
succinic acid (43mM) in O.IM phosphate buffer, pH 7.4. The assay mixture was 
incubated at 37 °C for 20 min before stopping the reaction with 0.8ml of a mixture 
containing 10% SDS and ethanol (1:2 (v/v). The formation of the formazan product 
was quantitated by spectrophotometry at 490nm using a UV-visible 
spectrophotometer (Pharmacia LKB-Ultrospeck III). The specificity of the INT 
reduction reaction of succinate dehydrogenase by the cell lysates was confirmed 
using the selective inhibitor malonate (43mM).
2.7 RNA extractions
RNA was extracted using RNAzol™ B (Biotecx Laboratories, Inc, USA) 
(Chomczynski & Sacchi, 1987). RNAzol™ B contains guanidinium thiocyanate, a 
chaotropic agent inhibiting RNAses. RNAzol™ B promotes the formation of 
complexes of RNA between guanidinium and water molecules and abolishes 
hydrophilic interaction of DNA and proteins.
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Cells to be extracted were harvested by removing the medium and lysing the cells in 
situ by adding RNAzol B. 4 ml were used for a 75 cm flask and 1 ml for a 4 cm well. 
Solubilisation of the cells was completed by passing the lysate a few times through a 
pipette until it became gelatinous. 1ml aliquots of the gelatinous homogenate and 
lOOpl chloroform were then transferred to 1.5ml Eppendorf tubes (previously 
autoclaved), and shaken vigorously for 15 seconds before transferring them to ice for 
5 min. Centrifugation of the samples at 12,000g for 15 min at 4 °C followed. After 
centrifugation the aqueous (upper) phase was transferred to fresh Eppendorf tubes 
and RNA was precipitated by the addition of an equal volume of isopropanol, 
incubation on ice for 15 min and collected by centrifugation at 12,000g for 15 m in  at 
4 °C. The RNA precipitate formed a white-yellow pellet at the bottom of the tube. 
The supernatant was removed and the RNA pellets were washed with 75% ethanol 
by vortexing and subsequent centrifugation at 12,000g for 8 min at 4 °C. The ethanol 
was then removed and the pellets were dried at 37 °C for 10-15 min. The RNA 
pellets were dissolved in a total volume of 200pl distilled water. The activity of 
RNases was minimised by wearing gloves at all times, cleaning the work surfaces 
and equipment with RNase ZAP (Invitrogen, BV) and using DEPC 
(diethylpyrocarbonate)-treated or sterile RNase-free water.
2.8 Cloning Techniques
2.8.1 Isolation of plasmid DNA from bacterial transformants
2.8.1.2 Alkaline lysis-diatomaceous earth method (Carter & Milton, 1993)
1.5 ml of overnight bacterial cultures grown in 2xYT medium (section 2.8.4) were 
centrifuged (14,000g, 30sec) and the supernatant discarded. The bacterial pellet was
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then resuspended by whirlimixing in 200pl of resuspension buffer I (50mM Tris, pH 
7.5; lOmM EDTA; 100 pg/ml RNase A). 200pl of lysis buffer I (0.2M NaOH; 1% 
SDS) were added and the tube was mixed by inverting it before allowing it to stand 
for 1-2 min at room temperature until the suspension was clear. 200pl of 
neutralisation buffer I (2.55M potassium acetate, pH 4.8) were added and the mixture 
was centrifuged (14,000g, 5min). The supernatant was then transferred to a fresh 
Eppendorf tube and 1ml of diatom suspension (4M guanidine thiocyanate; 20mM 
Tris, pH 7.0; 20mM EDTA; lOmg/ml size-fractionated diatoms) was added. The 
supernatant/diatom suspension was left to stand at room temperature for 5 min, to 
allow the plasmid DNA to bind. The diatoms were kept in suspension during this 
time by occasional invertion. The suspension was centrifuged (14,000g, 30sec) to 
pellet the diatoms, the supernatant was discarded and the pellet was washed twice 
using 1ml of pellet wash solution (O.IM NaCl; lOmM Tris, pH 7.5; 2.5mM EDTA; 
50% ethanol) each time and pelleting the diatoms as before. The diatoms were then 
washed with 1ml of acetone and centrifuged (14,000g, 30sec), the acetone was 
discarded and the pellet was left to dry for approximately 2 min at 65 °C. To elute 
the plasmid DNA the pellet was resuspended in lOOpl of distilled water and 
incubated at 65 °C for 2 min with frequent inverting to keep the diatoms in 
suspension. The suspension was then centrifuged (14,000g, 2min), to remove the 
diatoms, and the supernatant was transferred to a fresh Eppendorf tube. Two pi of 
the preparation generally contained sufficient plasmid DNA for easy visualisation 
and quantitation on an agarose gel.
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2.8.1.2 S.N.A.P. Method
DNA preparations were performed with the S.N.A.P.™ miniprep kit (Invitrogen 
BV), as per the manufacturer’s instructions. 0.5-1 pi of the preparation generally 
contained sufficient plasmid DNA for easy visualisation. Where necessary, DNA 
was quantified on agarose gel by reference to lambda DNA markers of known 
concentration.
2.8.1.3 Alkaline lysis /  PEG precipitation method
This method was used to prepare plasmid DNA for automated sequencing (section 
2.10). It is a modified mini alkaline-lysis/PEG precipitation procedure as stated in 
PRISM™ Ready Reaction DyeDeoxy™ Terminator cycle sequencing kit protocol 
Rev. A (Applied Biosystems, Inc.). This method includes a PEG precipitation step 
that yields high-quality super-coiled plasmid DNA relatively fi*ee of contaminating 
chromosomal DNA or RNA.
2.8.2 Purification of DNA
2.8.2.1 Ethanol precipitation o f plasmid DNA
This method was mainly used to further purify plasmids prepared by the diatom 
mini-prep method. The volume of the sample was determined and 0.033 volumes 
3M sodium acetate, pH 5.2 were added followed by 2.5 volumes ethanol. The 
suspension was thoroughly mixed and left to stand for 45 min in an alcohol/dry-ice 
bath. It was then centrifuged (14,000g, 12min), the supernatant discarded and the 
pellet washed twice with 70% ethanol. The pellet was then left to dry on a heating 
block (37 °C, 5min) and was resuspended in an appropiate volume of deionised 
water.
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2.8.2.2 Precipitation ofPCRproducts
The liquid paraffin was removed from the PCR product (section 2.9) by extracting 
twice with ether, any ether left was evaporated by placing the tube on a 65 °C heating 
block. The PCR product volume was measured and an equal volume of 4M 
ammonium acetate followed by 2 volumes of isopropanol were added. The 
preparation was mixed, left to stand at room temperature for lOmin and centrifuged 
(14,000g, lOmin). The supernatant was discarded and the pellet was washed with 
70% ethanol and centrifuged (14,000g, 5min); this step was repeated twice. The 
pellet was then dried at 37 °C and resuspended in either 25pl water if the PCR 
product was to be made blunt-ended or 90pl water if it was to be restriction digested.
2.5.2.3 Purification o f PCR products, DMA plasmids, and fragments
PCR products were purified using the Wizard™ clean-up system (Promega 
Corporation, UK). This method uses a resin to bind DNA. DNA eluted is clean from 
enzyme buffers, dNTPs, and polymerases used during the generation of sticky- or 
blunt-ends. It was used as per the manufacturer’s instructions.
One of the two following methods was used to purify DNA plasmids.
i) Gel purification: DNA was electrophoresed through agarose gels as described in 
section 2.8.5. Fragments of DNA were purified using the QIAquick gel extraction 
kit (Qiagen Ltd., UK) as per the manufacturer’s instructions. This method combines 
microspin technology and the selective property of silica-gel membranes to bind only 
DNA. DNA binds to the membrane while any contaminants pass through during 
centrifugation.
ii) Wizard™ clean-up system as above.
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2.8.3 Enzymes
2.8.3.1 Restriction enzyme digests
Restriction digestions were carried out according to manufacturer’s instructions 
using the buffers provided by the manufacturer. The total reaction volume was 
adjusted as necessary according to the amount of DNA to be digested. For analysis 
purposes, 0.2pg DNA were digested with 1 unit of enzyme in a total reaction volume 
of lOpl, usually at 37 °C for l-2hrs. Larger reaction volumes and double digests 
were incubated for 3hrs. Overnight blunt-end digests were carried out at 30 °C. 
Digested PCR products were cleaned using the Wizard™ clean-up system (section 
2 .8.2).
2.8.3.2 Production o f blunt-ended DNA
PCR can often leave “ragged ends” on amplified molecules. These can be repaired 
using T4 DNA polymerase. The polymerase proceeds in a 5' to 3' direction; it fills in 
a 5' overhang and chews back a 3' overhang.
The following were added to 25 pi of PCR product:
3 pi 1 Ox T4 DNA polymerase buffer
Ipl 5mM dNTP mix (5mM each ofdATP, dGTP, dCTP, dTTP)
Ipl 5mg/ml BSA
Ipl (0.8 unit) T4 DNA polymerase 
The reaction mixture was incubated for 30min at 37 °C and cleaned using the 
Wizard™ clean-up system (section 8.2).
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2.8.3.3 Déphosphorylation o f DNA
Calf intestinal alkaline phosphatase (CIP) was used to dephosphorylate linearised 
vector DNA (Sambrook et a l, 1989). Digested or blunt-ended vector DNA was 
purified using the Wizard™ clean-up system (section 2.8.2). 5pi lOx CIP buffer and 
Ipl CIP were added to 45pl DNA. Digested DNA was incubated at 37 °C for 30min 
and a second aliquot of CIP was added followed by a second incubation (30min, 37 
°C). Blunt-ended DNA was incubated at 37 °C for 15min and then at 56 °C for 
another 15min. A second aliquot of CIP was the incubation repeated. The 
dephosphorylated vector was then cleaned using the Wizard™ clean-up system 
(section 2.8.2).
2.8.3.4DNA ligations
DNA ligations were performed using T4 DNA ligase using the same conditions for 
both sticky- and blunt-ended substrates. Vector DNA was appropriately digested (or 
blunt-ended), dephosphorylated if required, purified and its concentration adjusted to 
1 Ong/pl. The ligation required a 3:1 molar excess of insert DNA to vector.
The following were added to long vector DNA in an Eppendorf tube kept on ice :
1 pi 1 Ox ligase buffer 
2pl 25% polyethylene glycol 
desired ng insert DNA 
distilled water to lOpl 
Ipl T4 DNA ligase
The reaction mix was overlain with liquid paraffin and incubated overnight at 16 °C. 
The ligation was stopped by the addition of 4pl 0.2M EDTA and 36pl water. The 
ligation products were used directly to transform competent bacteria (section 2.8.4).
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2.8.4 Growth and manipulation of bacteria cells
2.8.4.1 Preparation o f competent E.coli DH5a cells
The host bacteria used throughout the cloning experiments were E.coli strain DH5a 
made competent by the method described by Inoue and coworkers (Inoue et a l, 
1990). Ten large (2-3mm in diameter) colonies were used to inoculate 250ml of 
SOB medium and incubated at 18 °C with shaking until mid log phase (0.6 at ODeoo). 
The culture was then cooled on ice for lOmin and centrifuged (2,500rpm, lOmin, 4 
°C). The cell pellet was resuspended in 80ml of ice-cold transformation buffer (TB) 
(lOmM Pipes; 55mM MnCb; 15mM CaCb; 250mM KCl; pH 6.7), incubated on ice 
for lOmin and centrifuged as before. The cell pellet was gently resuspended in 20ml 
TB and DMSG was added with gentle swirling to a final concentration of 7%. The 
suspension of cells was incubated on ice for lOmin before being aliquoted into 0.5ml 
in prechilled cryotubes and immediately stored in liquid nitrogen. Prior to 
transformation the cells were thawed on ice.
2.8.4.2 Transformation o f E.coli DH5 a  cells with plasmid DNA
2-5ng of ligated mix (section 2.8.3) was incubated on ice with 50pl DH5a for 30min 
before heat shocking at 42 °C for 45sec, and returning to ice for 5min. 200pl 2xYT 
were added and the preparation was incubated for Ihr at 37 °C. The transformation 
mix was then spread onto 2xYT agar plates containing ampicillin and incubated 
overnight at 37 °C. Colonies were picked and inoculated in 3ml 2xYT medium 
containing ampicillin (50pg/ml) overnight and these cultures were processed as 
required. For plasmids that enable blue/white selection, plates with 2xYT agar 
containing 5-bromo-4-chloro-3-indolyl-;^D-galactoside (X-Gal) and IPTG were 
used. IPTG constitutively induces the expression of the P-galactosidase gene (lacZ)
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which reacts with X-Gal and produces a substance with a characteristic blue colour. 
Insertion of DNA fragments into the multicloning site (MCS) of these vectors 
disrupts the lacZ gene and bacterial cells containing the recombinant plasmids will 
be white.
2.8.5 Agarose gel DNA electrophoresis 
Gel electrophoresis
Electrophoresis grade agarose was dissolved in IxTBE to either 1.2 or 2% by boiling 
and poured into a flat-bed electrophoresis apparatus. Once set, IxTBE was added to 
the gel tank, and the gel comb was removed. Samples were mixed in equal volume 
with 2xTBE containing 20% glycerol and marker dyes (bromophenol blue and 
xylene cyanol FF) and loaded. The gel was electrophoresed at 100 to 150 volts for 
various length (30 -  90 min) depending on requirements for a small (50 x 70 mm) 
gel. Ethidium bromide was added in both dissolved agar and running buffer at a 
concentration of 0.5pg/ml. DNA bands were visualised using a UV transilluminator 
and an image taken using the Gel documentaion system (GDS) (UVP Imagestore 
5000).
DNA size markers
lOpg bacteriophage Lambda DNA (IDNA) was dissolved in lOOpl water and was 
digested by the addition of 12.5pl lOx EcoRi buffer, 50units EcoR\ enzyme, and 
50units enzyme followed by incubation at 37 °C for 3hr. To the digested
IDNA 125 pi 2xTBE sample buffer were added. 8pi of the marker was typically 
loaded on a gel. The DNA size markers produced were 21.7; 5.15; 5; 4.27; 3.48; 
1.98; 1.9; 1.59; 1.37; 0.94; 0.83; 0.56 kb.
63
Chapter 2
2.9 Polymerase chain reaction
2.9.1 Preparation of oligonucleotide primers
Oligonucleotide primers were chemically synthesised on an “Applied Biosystems” 
synthesiser, model 3ISA. Each oligonucleotide was cleaved from the support matrix 
using fresh ammonia (specific gravity 0.88, BDH AnalaR). 1.5ml ammonia was 
passed through the column at a rate of 0.5ml every 20min. The ammonia 
oligonucleotide-containing solution was incubated at 55 °C overnight to deprotect the 
oligonucleotide. The ammonia was then removed by evaporation and the 
oligonucleotide was ethanol precipitated overnight at -20 °C by the solution of 1/10 
volume 3M sodium acetate, pH 5.0 and 3 volume absolute ethanol. The DNA was 
then pelleted (14,000g, lOmin), washed twice with 80% ethanol, and resuspended in 
approximately lOOpl water. The concentration of the oligonucleotide was measured 
in a spectrophotometer.
2.9.2 Reverse Transcription-PCR amplification of RNA (RT-PCR)
PCR amplification of RNA was carried out in two stages, the first was the generation 
of cDNA using reverse transcriptase, followed by PCR amplification to generate 
DNA.
2.9.2.1 Reverse transcription o f RNA
This reaction utilised 2-1 Opg of messenger RNA into cDNA and was carried out on 
ice. The following were added to a sterile RNase-free Eppendorf tube:
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5pi (2-1 Opg) RNA
lOpl 5x first strand buffer
5 pi lOOmM DTT (dithiothreitol)
5pl 5mM dNTP mix (section 2.8.3)
Ipl RNAseIn (RNase inhibitor)
1.7pl 2BCend (section 4.2)
22.3 pi distilled water
The preparation was mixed, 2.5pl cloned Moloney murine leukemia reverse
transcriptase enzyme (M-MLV RT) (10,000 u/ml) were added, and the reaction was
incubated at 37 °C for Ihr. The final reaction mixture was named reverse
transcription mix (RT mix).
2.9.2.2 PCR amplification
A  typical PCR reaction mix was made by the addition of the following to a 0.5ml
Eppendorf tube:
5 pi RT mix
lOpl 2mM dNTP mix (section 2.8.3)
lOpl 2BCstart (section 4.2) (diluted 1:100 with water)
lOpl 2BCend (section 4.2) (diluted 1:100 with water)
lOpl lOx PCR buffer with MgCb
51pl distilled water
4pl 50% glycerol
Ipl Taq DNA polymerase was then added, the reaction was overlayed with 80pl of
liquid paraffin to prevent evaporation and incubated in a thermocycler (Quattro TC-
40, Biosystems, UK), incorporating 1 cycle of dénaturation (72 °C, 20sec), 35 cycles
of dénaturation (94 °C, 30sec), annealing (55 °C, 30sec) and extension (72 °C,
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90sec), followed by 1 cycle of extension (72 °C, 5min) before holding the 
temperature at 4 °C (if PCR was carried out overnight). The PCR product was then 
checked on an agarose gel (1.2%), and processed as described in section 2.8.2.
2.9.3 PCR amplification of DNA
A reaction mix was set up as follows:
1 Opl (5pg) template DNA (2BC cDNA, section 4.2.1)
lOpl 2mM dNTP mix (section 2.8.3)
1 Opl 2BCstart (section 4.2) (diluted 1/100 with water)
1 Opl 2Bend (section 4.2) (diluted 1/100 with water)
1 Opl 1 Ox PCR buffer with MgCl2
46pl distilled water
4pl 50% glycerol
Ipl Taq DNA polymerase was then added, and the reaction mix was overlayed with 
80pl of liquid paraffin to prevent evaporation. The reaction mix was then incubated 
in a thermocycler incorporating 1 cycle of dénaturation (72 °C, 30sec), 40 cycles of 
dénaturation (94 °C, 30sec), annealing (60 °C, 30sec) and extension (72 °C, 30sec), 
followed by 1 cycle of extension (72 °C, lOmin) before holding the temperature at 4 
°C. The PCR product was then checked on an agarose gel (1.2%), and processed as 
described in section2.8.2.
2.10 DNA sequencing
DNA sequence determination was performed using an automated sequencer, model 
373A by Applied Biosystems and ABI prism dye terminator ready reaction cycle
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sequencing kit according to manufacturer’s instructions and specific primers. This 
was provided as a service within the School of Biological Sciences and performed by 
a technician associated with the sequencer.
2.11 Northern blotting
2.11.1 RNA electrophoresis 
Denaturing agarose gel
1.5% denaturing gel was prepared by mixing 3g agarose with 20ml lOxMOPS and 
170ml water and boiling to dissolve. The mixture was allowed to cool to 60 °C 
before adding 30ml formaldehyde and cast into a 160 x 150mm tray and left to set 
(l-2hr).
Electrophoresis
The gel was electrophoresed in IxMOPS buffer at 150mAmp for 2hr. The RNA 
samples to be electrophoresed were prepared as follows: 5pi RNA (< 20pg) were 
mixed with 15 pi sample buffer, the sample was denatured by heating for 5min at 60 
°C and 10pi glycerol containing bromophenol blue and xylene cyanol FF dyes were 
added. The RNA markers used (eukaryotic RNA, 28 + 18S; procaryotic RNA, 23 + 
16S) were prepared the same way.
2.11.2 Northern transfer
Following RNA electrophoresis (section 2.11.1), RNA was transferred onto a 
nitrocellulose membrane by adaptation of the method of DNA transfer as described 
in (Sambrook et a l, 1989). The gel was soaked in three changes of 20xSSC (175g
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NaCl; 88.2g sodium citrate; water to 11), over a period of Ihr and transferred to wet 
nitrocellulose membrane (‘Gelbond’ Gelman Sciences, USA) in 20xSSC overnight 
by capillarity. The gel was inverted onto two pieces of 3MM paper pre-soaked with 
20xSSC, the 3MM being supported above a reservoir of 20xSSC, with the 3MM 
acting as a wick. A piece of membrane was placed on top of the gel followed by two 
pieces of 3MM paper pre-soaked in 20xSSC and two pieces of dry 3MM paper. 
Cappillary action was used to achieve the transfer and water uptake was promoted 
using a stack of dry tissues piled on top of the blot and held in good contact using a 
500g weight. The membrane was then UV cross-linked using a UV Stratalinker 
1800 (Stratagene) to fix the RNA. The membrane tracks containing the RNA 
markers were cut off, soaked in 5% acetic acid for 15min and stained for lOmin in 
methylene blue (0.5M sodium acetate, pH 5.2 with 0.04% methylene blue), followed 
by a lOmin wash with water to allow for visualisation of the RNA markers. The 
remaining membrane was hybridised as described in section 2.11.3.
2.11.3 Blot hybridisation 
Preparation of^^P labelled DNA probe
The DNA used to produce the probe was gel-extracted as described in section 2.8.2.3 
and was radiolabelled using the random hexanucleotide primed method of Feinberg 
& Vogelstein (Feinberg & Vogelstein, 1983). DNA (lOng in 8.8pl) was denatured 
by boiling for 5min followed by rapid cooling on ice. The denatured DNA was then 
mixed with the following:
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3 pi OLE
Ipl random hexanucleotide (1 mg/ml)
1.2pl BSA(5mg/ml)
O.Sunit Klenow fragment of DNA polymerase
20nCi dATP
The reaction mix was incubated at room temperature overnight and the reaction was 
stopped by the addition of 70pl stop/quench solution. Prior to its use the probe was 
denatured by boiling for 2min followed by incubation on ice for 2min.
Hybridisation
The UV cross-linked membrane (section 2.11.2) was added to a bottle containing 
pre- hybridisation solution and the bottle was rotated in a Hybaid™ Hybridisation 
oven overnight at 65 °C. labelled DNA probe was then added and the membrane 
was hybridised under the same conditions. The membrane was then washed three 
times in hybridisation wash solution (by rotation, 30min, 65 ®C) and exposed to X- 
ray film (Fujifilm) for 12-24hr at -70 °C with an intensifier screen.
2,12 Separation o f proteins in SDS-poIyacrylamide gels
2.12.1 SDS-polyacrylamide-gel-electrophoresis (SDS-PAGE)
The apparatus used was the Bio-Rad protean mini cell (Bio-Rad Lab. Ltd, UK). The 
proteins were separated on a 10% resolving gel. The gel was prepared and poured 
between clean mini-gel glass plates and was allowed to set for Ihr under an overlay 
of butanol saturated with water. The overlay was then discarded and the gel surface 
rinsed with water before pouring the stacking gel and inserting a comb to form the 
wells for the sample loading. Once the stacking gel was set the comb was removed,
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the gel immersed into the tank containing running buffer and the samples loaded. 
The gel was electrophoresed at 150V for 45-60min. The samples were prepared by 
boiling them in Ix loading dye for 3min. After electrophoresis the proteins were 
detected by Kenacid blue staining or were Western blotted.
The Mr markers used depended on the process of the gel. For Kenacid blue staining 
the markers used were of Mr range 14,000-70,OOODa. Their precise sizes were 
66,000; 45,000; 36,000; 29,000; 24,000; 20,100 and 14,200 Da. For Western 
blotting the markers used were the kaleidoscope pre-stained standards (Bio-Rad). 
Their sizes (Da) and colours were:
Myosin Blue 210,000
P-galactosidase Magenta 135,000
Bovine serum albumin Green 80,000
Carbonic anhydrase Violet 42,700
Soybean trypsin inhibitor Orange 31,500
Lysozyme Red 18,200
aprotinin Blue 7,500
2.12.2 Kenacid blue staining
The protein gel was shaken in a box containing stain (1.25g kenacid brilliant blue; 
125ml propanol; 50ml acetic acid 50ml; 325ml water) for Ihr. The gel was then 
destained with successive changes of destain (125ml propanol; 50ml acetic acid; 
325ml water) until the desired background had been achieved and the bands were 
clear.
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2.13 Western blotting
2.13.1 Protein transfer
The proteins were separated by SDS-PAGE (section 2.9.1) and the gel was 
equilibrated by soaking in three changes of transfer buffer (25mM Tris; 192mM 
glycine; 20% methanol) over a period of 20min, before being transferred to 
nitrocellulose membrane (Immobilon™-P, Millipore) using a Semi-dry blotter 
(Trans-blot® cell, Bio-Rad Laboratories Ltd, UK) per the manufacturer’s 
instructions. On the bottom electrode (positive) four pieces of 3MM papers pre- 
soaked with transfer buffer, a piece of membrane soaked in transfer buffer, the gel, 
and four more pieces of 3MM papers pre-soaked with transfer buffer were placed in 
this order. The top electrode was then placed on top (negative) and the gel was 
electroblotted at 10-15V for 15-30min.
2.13.2 Antigen detection
The proteins transferred on to nitrocellulose membrane act as antigens than can be 
detected by visualising bound antibody. Detection of the proteins is carried out by 
ECL (Enhanced Chemiluminescence, Pierce, UK), a light emitting non-radio active 
method for detection of specific immobilised antigens using a secondary antibody 
conjugated with horseradish peroxidase (Ab-HRP).
The Western blot was slowly shaken in blocking buffer (rinse buffer (Ix PBS with 
0.5ml/l Tween 20) plus 5% dry milk) for Ihr or overnight. The blot was then briefly 
washed in rinse buffer, before being incubated for l-2hr in primary antibody diluted 
in rinse buffer containing 10% PCS. The blot was then washed with rinse buffer to
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remove any unbound antibody (3 x 5min washes) and incubated in diluted secondary 
Ab-HRP as before. The blot was washed with rinse buffer (6 x 5min) and the 
proteins were detected by ECL using the HRPL substrates A and B by National 
Diagnostics per the manufacturer’s instructions. The blot was drained and equal 
volumes of substrates A and B were poured on top of it and left for Imin. Excess 
solution was removed, the membrane was wrapped in cling film and exposed to X- 
ray film. Exposure times varied depending on the strength of the signal.
2.14 Expression of recombinant proteins in Escherichia coli
The DNA sequences to be expressed were cloned in pGEX glutathione S-transferase 
(GST) gene fusion vectors (Pharmacia Biotech, Inc) using standard cloning 
techniques.
2.14.1 Induction of the fusion proteins
1ml of an overnight culture of transformed E.coli containing the recombinant vector 
grown in 2xYT was added to 9ml fresh 2xYT and incubated with shaking at 37 °C 
until an ODgoo of 0.6-0.8 (log phase) was reached. Fusion protein expression was 
induced by the addition of O.IM IPTG to a final concentration of ImM and the 
culture was incubated by shaking for another 5hr. The culture was centrifuged 
(14,000g, 2min) and the pellet from 1ml of culture was lysed by resuspension in 50- 
lOOpl of 1 X loading dye and boiling for 3 min before loading and separating through 
a 10% SDS-PAGE (section 2.12).
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2.14.2 Purification and screening of induced fusion proteins
The procedure was an adaptation of the protocol “Screening of pGEX recombinants 
for fusion protein expression” by Pharmacia Biotech, Inc (third edition, revision 2). 
1ml cultures before and after induction (section 2.14.1) were centrifuged (14,000g, 
2min) and the pellets resuspended in 300pl IxPBS buffer. The resuspended cells 
were then lysed by sonication (3xl0sec, 10pm using a Soniprep 150 probe 
sonicator). The lysed cells were centrifuged (14,000g, 5min) and the supernatant 
was added to a fresh Eppendorf tube. 20pl of 50% slurry of Glutathione Sepharose 
4B (133pl of Glutathione Sepharose 4B beads were washed twice with IxPBS buffer 
and finally resuspended in lOOpl IxPBS buffer) were added to the supernatant and 
mixed gently for 5min at room temperature. lOOpl IxPBS buffer were added, the 
preparation centrifuged (14,000g, 5sec) to sediment the beads and the supernatant 
was discarded. This process was repeated two more times. The protein was finally 
eluted by adding lOpl glutathione elution buffer (lOmM reduced glutathione in 
50mM Tris-HCl, pH 8.0) and incubating at room temperature for 5min. The beads 
were then sedimented by centrifugation (500g, 5min) and the supernatant (10-20pl) 
transferred to a fresh Eppendorf and stored at -20 °C. The beads were also stored at 
-20 °C. 10-20pl of samples that had been removed at each step throughout this 
procedure were mixed with IxSDS-PAGE loading dye and separated through 10% 
SDS-PAGE gel.
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2.15 Transfection of mammalian cells
2.15.1 Lipofectin mediated transfection of COS-1 cells
Transient transfection of COS-1 cells was performed using lipofectin® reagent 
(Gibco-BRL, Paisley, UK) as per the manufacturer’s instructions.
Solutions
Transfection medium: Qpti-Mem® I Reduced Serum Medium (Gibco-BRL, 
Paisley, UK).
Solution A: por each transfection l-2pg DNA diluted in lOOpl transfection medium. 
Solution B: y or each transfection lOpl lipofectin® reagent diluted in lOOpl 
transfection medium and allowed to stand for 30min.
Transfection cocktail: por each transfection solution A was mixed with solution B, 
allowed to stand for 15min and 0.8ml of transfection medium was added.
Transient transfection
In a 6-well tissue culture plate 1-2x10^ COS-1 cells in 2ml DMEM were seeded and 
incubated (at 37 °C in a humidified atmosphere of 5% CO2 in air) until the cells were 
40-60% confluent. The cells were then washed with 2ml transfection medium and 
overlaid with the transfection cocktail. The cells were incubated as before for 24hr. 
The transfection cocktail was then replaced with pre-warmed (37 °C) DMEM and the 
cells incubated as before for 48hrs. The cells were harvested as required.
2.15.2 Transfection efficiency
The transfection efficiency was estimated by the expression of P-galactosidase (P- 
gal), in mammalian cells.
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COS-1 cells were grown on cover slips and transfected (section 2.15.1) with the 
vector pCHllO expressing the gene that encodes for P-gal. At the end of the 
transfection the cells were washed with 2ml IxPBS and fixed by overlaying them 
with fixing solution (2% formaldehyde, 0.2% glutaraldehyde in PBS) for 5min. The 
cells were then washed with 2ml IxPBS twice and stained for 2hr with staining 
solution (0.1% X-gal (in DMSO), 5mM potassium ferricyanide, 5mM potassium 
ferrocyanide, 2mM MgCb in PBS buffer). The cells were then rinsed and examined 
under the microscope. Cells expressing the pCHl 10 vector were blue in colour. The 
transfection efficiency was calculated by direct microscopic examination and 
counting using a Zeiss light microscope.
2.16 Reverse phase high performance liquid chromatography of 
nucleotides and nucleosides
Monolayers of T47D cells (total 1.5 x 10  ^cells) were infected with polio I (or mock- 
infected) (section 2.3.3). At given times after infection, the cell monolayers were 
washed with RPMI-1640 and 200pl ice-cold 1.5M perchloroacetic acid (PCA) was 
added. The cells were then detached by gentle scrapping and stored in Eppendorf 
tubes at —70 °C. Immediately before analysis, the cell suspensions were thawed by 
immersing the tubes in a 37 °C water-bath, centrifuged (12,000g, 5min) and the 
supernatant added to a fresh Eppendorf tube placed on ice. The pH of the 
supernatant was increased to 5 by addition of lOM potassium hydroxide (KOH) and 
further increased to 7 by the slow addition of potassium bicarbonate (KHCO3). The 
suspension was then centrifuged (12,000g, 5min) and the supernatant transferred to
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fresh Eppendorf tubes. 20pl of supernatant were added to 180pl water and reverse 
phase high performance liquid chromatography (RP-HPLC) was carried out.
RP-HPLC analysis was performed using a Shimadzu EC 1 Oat system with a 
Techsphere 5pm ODS Cig column (25cm x 4.6mm) eluted with O.IM potassium 
phosphate containing 8mM tetrabutylammonium hydrogen sulphate (adjusted to pH
6.0 with 9M KOH) (solvent A) and a 60:40 mixture of solvent A and acetonitrile (pH 
6.73) (solvent B). The sample injection volume was 50pl (injection of larger 
volumes can lead to air also being injected thus causing damage to the HPLC 
column), and a non-linear gradient of the following type was employed at a flow rate 
of 1.3ml/min: 0-2.5min 0% B; 2.5-5min 0-20% B; 5-lOmin 20-40% B; 10-13min 40- 
100% B; 13-18min 100% B; 18-25min 100%B.
Adenosine triphosphate (ATP), adenosine diphosphate (ADP), and adenosine 
monophosphate (AMP) were detected by ultraviolet absorbance (u.v.) at their 
optimum wavelenght 259nm, using a Shimadzu SPD-IOa u.v./visible detector and 
were quantified by the area of their individual absorbance peaks, which was linearly 
related to their concentration. Figure 2.1 shows a representative chromatogram for 
the separation of ATP, ADP, AMP, adenosine and inosine. Their HPLC retention 
times were: ATP: 16.3; ADP: 13.1; AMP: 10.6; adenosine: 9.0; inosine: 6.4.
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Figure 2.1 Separation of ATP (+), ADP (•), AMP (A), adenosine (,) and 
inosine (♦) by RP-HPLC. A SOpl mixture containing lOOpM of each nucleotide 
and nucleoside was injected onto a Techsphere 5pm ODS Cig column and the elution 
profile of each nucleotide and nucleoside was followed at 259nm using a using a 
Shimadzu SPD-IOa u.v./visible detectors
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2.17 Fluorescence microscopy to monitor nuclear changes
For the analysis of changes in nuclear morphology of cells, fluorescence microscopy 
was applied. Cells were grown in 6-well plates on coverslips and infected with polio 
I as described in section 2.3.3. Mock-infected cells that had been treated in the same 
way except for the absence of virus were used as controls. At appropriate time 
points after infection the cells were fixed in 4% (v/v) formaldehyde at room 
temperature for 30min. The forlmaldehyde was then aspirated and nuclei were 
stained by the addition of 1ml PBS containing the nucleic acid stain Hoechst 33342 
(6pg/ml) and incubation at room temperature for 5min. Hoechst 33342 is a water- 
soluble cell-permeant minor groove-binding DNA bisbenzimide stain that fluoresces 
bright blue upon binding to DNA. The coverslips were then washed with 1ml PBS 
and nuclei were visualised using a Zeiss Axiovert fluorescence microscope 
(excitation wavelength, 360nm, emmision wavelength, >420nm).
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EFFECT OF POLIOVIRUS INFECTION ON 
MITOCHONDRIAL FUNCTION
3.1 Aims of the study
As reviewed in chapter 1, enteroviruses have a tropism for muscle cells and have 
been implicated in the aetiology of CFS. Abnormal mitochondria have been reported 
in CFS patient muscle biopsies and defects in energy supply have also been 
suggested as a possible cause for this syndrome.
In view of these data the hypothesis that PV infection alters the function of 
mitochondria, in particular with respect to energy production was tested. Different 
mammalian cell lines were infected with PV and their cellular and mitochondrial 
function followed. PV was the virus of choice since it has been associated with CFS 
and it is a well-characterised virus.
3.2 Effect of PV infection on cellular respiration
The basal respiratory rates of COS-1 (8x10^ cells/ml) and T47D (3.3 x 10  ^cells/ml) 
cells following infection with polio I (moi 15 pfu/cell) were monitored by measuring 
total cellular oxygen consumption in a thermal-jacketed Clarke type electrode as 
described in section 2.5.1. The basal cellular respiration for COS-1 and T47D was 
4.30 ± 0.27 pM 0 2 /min/lO^ cells and 1.23 ± 0.10 pM Oz/min/lO^ cells, respectively. 
The addition of antimycin A (AA) (2 pg/ml) (an inhibitor of complex III) (table 3.2) 
while recording the basal respiratory rate of uninfected cells, was found to 
immediately block cellular respiration indicating that nearly all of the cellular 
consumption of oxygen was attributed to the mitochondria (fig. 3.1).
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Figure 3.1 Antimycin A blocks cellular consumption of oxygen. T47D cells 
(3.3 X 10  ^ cells/ml) were transferred into the chamber of a Clark-type oxygen 
electrode and their basal rate of oxygen consumption monitored before and after the 
addition of AA (2 pg/ml). Arrow indicates the addition of AA.
Infection with polio I resulted in a decrease in the cellular respiration of both cell 
lines as shown in figures 3.2a and 3.2b. The basal respiratory rate of COS-1 cells 
was 4.30 ± 0.27 pM Oz/min/lO^ cells. Following infection this rate decreased by 
45% within a period of 4hr (associated probability P < 0.05). T47D cells exhibited a 
much lower basal rate of respiration of 1.23 + 0.10 pM 0 2 /min/lO^ cells. However, 
infection of the cells also resulted in a 25% decrease within 4hr post-infection (P < 
0.05). The morphology of the cells following infection was examined and it was 
found that rounding up of the cells (a typical enterovirus induced change) was not 
observed until 8 hr post-infection (Koundouris et al., 2000). Use of propidium 
iodide, a membrane-impermeant dye that stains by intercalating into nucleic acid
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molecules, showed that increased plasma membrane permeability of the infected 
cells did not occur until 8 hr post-infection (Koundouris et al., 2000).
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Figure 3.2a Cell respiration of COS-1 cells infected with polio I. Confluent 
monolayers of COS-1 cells were infected with polio I and the basal rate of oxygen 
consumption at 0, 2 and 4 hr post-infection was recorded using a Clark-type oxygen 
electrode (section 2.5.1). Each point (triangles, mock-infected; squares, polio I- 
infected) represents the mean ± SE of three separate experiments (*P < 0.05).
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Figure 3.2b Cell respiration of T47D cells infected with polio I.
Confluent monolayers of T47D cells were infected with polio I and the basal rate of 
oxygen consumption at 0 and 4 hr post-infection was recorded using a Clark-type 
oxygen electrode (section 2.5.1). Each point (triangles, mock-infected; squares, 
polio I-infected) represents the mean ± SE of three separate experiments (*P < 0.05).
3.3 Mitochondrial respiration
Since cellular respiration could almost entirely be attributed to mitochondrial 
respiration, it would appear that the inhibition of respiration following PV infection 
was the consequence of interfering with the mitochondrial respiration chain. During 
electron transport within mitochondria, electrons flow from NADH to oxygen via
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nicotinamide adenine dinucleotide (NADH) via NADH dehydrogenase (complex I), 
cytochrome b-ci (complex III) and cytochrome oxidase (complex IV) (fig. 3.3). The 
terminal oxidase catalyses the conversion of oxygen to water.
ATP ATP ATP
FADH
MATRIXADP+P ADP+P 
fumarate
ADP+P
NA D H +ir
NAD’ K
cinate
A INNERMEMBRANE
\  H’ .
INTERMEMBRANE
SPACE
Figure 3.3 The respiratory chain showing the flow of electrons from NADH 
to oxygen. The mitochondrial respiratory chain comprises complexes I (NADH- 
ubiquinone reductase), II (succinate-ubiquinone reductase), III (ubiquinol- 
cytochrome c) and IV (cytochrome c oxidase). These are linked by ubiquinone (Q) 
and cytochrome c. The latter are mobile molecules which diffuse through the 
membrane. Q serves to shuttle electrons from complexes I and II to complex III. 
Similarly, cytochrome c shuttles electrons from complex III to complex IV. The 
synthesis of ATP via the respiratory ehain is the result of two coupled processes: 
electron transport and oxidative phosphorylation.
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Therefore, the effect of PV infection on the mitochondrial respiration was directly 
examined. To accomplish this, COS-1 cells were resuspended in a buffer that 
mimicked the intracellular environment, added to the chamber of a Clark-type 
oxygen electrode and permeabilised with saponin as described in section 2.5.2. 
Saponin removes the barrier function of the plasma membrane without disturbing the 
mitochondrial function of the cells (Kass et al., 1993). Metabolic supplements 
providing electrons to complexes I and II (table 3.1), and inhibitors of complexes I 
and III (table 3.2), were added accordingly into the chamber.
Pyruvate (10 mM) -  Malate (1 mM) Combined introduce electrons into
complex I
Succinate (20 mM) An electron donor for complex II
Table 3.1 Metabolic supplements of complex I and II of the respiratory 
chain used in this study.
Rotenone (2 pg/ml) Blocks NADH dehydrogenase (complex I) and thus
prevents the transfer of electrons from complex I to 
ubiquinone.
Antimycin A (2 pg/ml) Blocks the respiratory chain at complex III between
cytochrome b and cytochrome ci, hence preventing the 
oxidation of both NADH and succinate.
Table 3.2 Inhibitors of complex I and II of the respiratory chain used in this 
study.
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Addition of pyruvate plus malate led to a slight stimulation of oxygen consumption 
in mock-infected COS-1 cells (fig 3.4a). This stimulation was inhibited by the 
addition of the complex I inhibitor rotenone. This block was overcome by the 
addition of succinate, which in turn was inhibited, by the addition of AA. The basal 
respiratory rate following succinate stimulation was always greater than when 
complex I was stimulated. This phenomenon is also seen in isolated rat liver 
mitochondria (George E.N. Kass, personal communication). Polio I infected cells 
were not as responsive to stimulation by either pyruvate plus malate or succinate as 
shown in figure 3.4b-c. Respiration stimulated by succinate was the most affected 
indicating that electrons added to complex II were not able to flow to complex III 
and oxygen following infection in contrast to mock-infected cells. These effects 
caused by polio I intensified with time as shown in figure 3.4.
To further identify the site of the electron flow block, attempts were made to restore 
the flow of electrons into cytochrome c. Therefore, the flow of electrons from 
cytochrome c to complex IV following polio I infection was also investigated. 
A,A,A',A-tetramethyl-l,4-phenylenediamine (TMPD), an artificial redox mediator 
that assists the transfer of electrons fi*om ascorbate to cytochrome c, and ascorbate 
were the metabolites used. Mock-infected and infected COS-1 cells were 
resuspended in intracellular-like solution, transferred to the chamber of a Clark-type 
oxygen electrode, permeabilised with saponin and their mitochondria energised with 
succinate (20 mM). The oxygen consumption by mitochondria was then blocked by 
the addition of AA. TMPD (0.5 mM) and ascorbate (1 mM) were then added and the 
oxygen consumption was almost fully restored in infected and mock-infected cells, 
as shown in figure 3.5a, demonstrating that the transport of electrons from
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cytochrome a to complex IV remains intact during infection. To further support this 
finding exogenous cytochrome c was added following the addition of TMPD and 
ascorbate and it was observed that oxygen consumption was not further stimulated 
(fig. 3.5b).
87
Chapter 3
PM SuccRota)
AA
PM
Rot Succ
AA
PM Rot Succ AA
\
30 i l i M O
30 sec
Figure 3.4 Effect of polio I infection on mitochondrial respiratory chain in 
COS-1 cells. COS-1 cells were infected with polio I or mock-infected (section
2.3.3). At 2 and 4 hours post-infection the cells were resuspended in a salt solution 
that mimicked the intracellular environment, added to the chamber of a Clark-type 
oxygen electrode and permeabilised with saponin (section 2.5.2). Oxygen 
consumption by mitochondria was monitored following the addition of pyruvate plus 
malate (PM), rotenone (Rot), succinate (Succ), and AA at the times indicated by the 
arrows. Respiration rates in mock-infected cells did not vary by more than 10% over 
a 4-hr period. One experiment representative of three is shown.
Trace a): mock-infected COS-1 cells.
Trace b): COS-1 cells 2 hr post-infection.
Trace c): COS-1 cells 4hr post-infection.
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Figure 3.5a Effect of polio I infection on electron transport through 
cytochrome c. COS-1 cells were infected with polio I or mock-infected (section 
2.3.3). At 2 and 4 hours post-infection the cells were resuspended in a salt solution 
that mimicked the intracellular environment, added to the chamber of a Clark-type 
oxygen electrode and permeabilised with saponin (section 2.5.2). The mitochondria 
were succinate-energised and oxygen consumption blocked with addition of AA. At 
the indicated time points (arrows), TMPD and ascorbate and cytochrome c were 
added. Trace a): mock-infected COS-1 cells.
Trace b): COS-1 cells 2 hr post-infection.
Trace c): COS-1 cells 4hr post-infection
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Figure 3.5b Effect of polio I infection on electron transport through 
cytochrome c, COS-1 cells were infected with polio I or mock-infected (section 
2.3.3). At 2 and 4 hours post-infection the cells were resuspended in a salt solution 
that mimicked the intracellular environment, added to the chamber of a Clark-type 
oxygen electrode and permeabilised with saponin (section 2.5.2). The mitochondria 
were succinate-energised and oxygen consumption blocked with addition of AA. At 
the indicated time points (arrows), TMPD and ascorbate and cytochrome c were 
added. Trace a): mock-infected COS-1 cells
Trace b): COS-1 cells 2 hr post-infection 
Trace c): COS-1 cells 4hr post-infection
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3.4 Succinate dehydrogenase activity of PV infected COS-1 cells
As shown in figures 3.4 and 3.5a, poliovirus infection resulted in the inhibition of 
electron flow from complex II to complex III. The site of inhibition was further 
investigated, and in the first approach, the flow of electrons from succinate through 
succinate dehydrogenase was investigated. Observed inhibition of succinate-driven 
respiration following polio I infection was fiirther investigated in order to establish 
whether the virus was responsible for the impairment of the electron transfer through 
complex II. Therefore, the activity of succinate dehydrogenase (SDH) following 
polio I infection was examined. SDH (Complex II) is a FAD-dependent protein that 
delivers electrons to coenzyme Q, bypassing the step catalysed by Complex I (fig.
3.3).
The activity of SDH of infected and mock-infected COS-1 cells was measured, as 
described in section 2.6, at 0, 2, 4 and 6 hr after infection. Polio I infected cells 
exhibited a considerably decreased activity of SDS by 55% (P< 0.01) in comparison 
to mock-infected cells as early as 2 hours after infection (table 3.3). SDH activity 
was restored at 4 hours after infection but only transiently since it was below the 
activity of the mock-infected cells and by 6 hours after infection it had decreased 
again to levels similar to those observed at 2 hours after infection. In the mock- 
infected cells, a slight increase in the activity of SDH was observed at 2 hours 
followed by a decrease at 6 hours. The cause of these changes is unknown, however, 
the levels of the activity of SDH of the infected cells were significantly lower at each 
time point.
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SDH activity 
(umol INT reduced/min/10^  cells)
Time (h) Control cells Infected cells n
0 8.6 ±1.0 6
2 10.7 ±1.2 4.82 ± 0.5* 8
4 10.4 ±0.5 8.33 ± 0.2" 4
6 7.6 ±0.9 4.77 ± 0.7" 4
Table 3.3 Effect of polio I infection on the activity of SDH.
Values for SDH activity are means ± SE of 4 to 8 experiments.
* Statistically different from control, P< 0.01.
**Statistically different from control, P< 0.05.
3.5 Mitochondrial membrane potential
A decrease in mitochondrial respiration would be expected to be reflected by 
additional changes in mitochondrial activity. Therefore, the effect of polio I 
infection on the membrane potential (ATm) of mitochondria was examined. In order 
to accomplish this task the fluorescent cationic lipophilic mitochondrial probe TMRE 
was employed. TMRE accumulates in mitochondria in response to their and its 
fluorescence is used to monitor AT^ (Lowe et a l, 1993; Metivier et a l, 1998).
92
Chapter 3
T47D cells were grown on round coverslips, infected with polio I (or mock-infected), 
incubated in medium containing TMRE, and TMRE fluorescent images were 
recorded and digitised for analysis of pixel intensity as described in section 2.4. The 
cellular distribution of TMRE was punctiform showing that the cationic probe 
accumulated in the mitochondria of the cells. The addition of the protonophore 
uncoupler of mitochondrial respiration carbonylcyanide m-chlorophenylhydrazone 
(20 pM) which causes the collapse of the mitochondrial A'Rm led to a typical 
redistribution of the fluorescence within the cell (loss of punctiform fluorescence as 
the dye leaves the mitochondria followed by the gradual loss of total cellular 
fluorescence). This confirmed that mitochondria were the primary site of TMRE 
accumulation. As shown in figure 3.6, polio I infection resulted in a time-dependent 
increase in TMRE fluorescence up to 6 hours in parallel with the changes observed 
in mitochondrial respiration. Similar data was observed in COS-1 cells (Christopher 
R. Johnson, personal communication). The distribution of TMRE remained 
punctiform and specific to cellular areas containing mitochondria, suggesting that it 
was indeed mitochondria that were displaying a brighter TMRE fluorescence. At 8 
hours after infection, the fluorescence began to decrease. Figure 3.7 shows digitised 
video images of TMRE fluorescent cells.
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Figure 3.6 Effect of polio I infection on TMRE fluorescence in T47D cells.
TMRE fluorescence of infected and mock-infected cells was analysed using MCID 
software (section 2.4). Each point (circles, mock-infected; squares, polio I-infected) 
represents the mean ± SE of three separate experiments (*, P< 0.05).
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3.6 Adenine nucleotides
As shown in the previous sections (3.3 and 3.4), polio I infection invoked a marked 
decrease in respiration, yet no drop in A'Fm occurred. One possible explanation for 
these findings would be that cells in response to infection decreased the production 
of ATP in order to maintain ATm under reduced respiration conditions. Therefore, 
the effect of polio I on respiration was further investigated by calculating the energy 
charge of the cells after infection and comparing it to that of mock-infected cells 
using RP-HPLC as described in section 2.16. T47D cells were infected and 4 hours 
after infection the concentration (nmoles/10^ cells) of ATP, ADP and AMP (table 
3.4) was calculated from the obtained RP-HPLC chromatograms.
Control cells 
Infected cells
Concentration (nmoles /1 0  cells)
ATP ADP AMP
1.15 + 0.06
1.20 ±0.06
0.21 ± 0.01
0.20 ± 0.02
0.061 ± 0.005
0.062 ± 0.006
Table 3.4 Effect of polio I infection on the concentrations of ATP, ADP and 
AMP. T47D cells were infected and 4 hours after infection analysis was carried out 
by RP-HPLC as described in section 2.16, and the concentrations of the nucleotides 
calculated. Values of concentranion are means ± SE of 3 experiments.
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The energy charge of the cells was computed using the equation:
[ATP] + l[ADP]
[ATP]+[ADP] + [AMP]
and it was found to be approximately the same for infected and mock-infected cells, 
(mock-infected: 0.88 ± 4.4 x 10'^, infected: 0.89 ± 2.2 x 10'^).
3.7 Summary
Polio I infection produced a rapid decrease in cellular respiration following infection 
in COS-1 and T47D cells. This was attributed to an inhibition of mitochondrial 
respiration. Stimulation by pyruvate plus malate or succinate was impaired but this 
inhibition could be overcome by the addition of TMPD and ascorbate. Addition of 
exogenous cytochrome c did not further stimulate respiration following TMPD and 
ascorbate stimulation. Therefore, the virus-induced inhibition of cellular respiration 
possibly occurred through inhibition of electron flow at complex II of the 
mitochondrial respiratory chain. The reason for this appeared to be an inhibition of 
the activity of SDH during infection. Unexpectedly, increased staining with the 
fluorescence probe TMRE was observed in infected cells suggesting an increase in 
A\\fm following infection. Moreover, ATP levels were not depleted after infection 
and the overall energy charge of the infected cells was the same to that of mock- 
infected cells. Taken together, these studies show that poliovirus infection leads to 
profound alterations in mitochondrial ftmction.
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EXPRESSION OF THE POLIOVIRUS NON-STRUCTURAL
PROTEINS 2B AND 2BC
4.1 Aims of this study
The work described in the previous chapter demonstrated that infection of 
mammalian cells with PV had significant effects on the respiration and membrane 
potential of mitochondria. In order to further investigate the cause of these defects 
the effect of individual PV proteins on normal mitochondrial activity was examined. 
This was intended to identify the specific factors that cause the inhibition of 
respiration and the increase in the mitochondrial membrane potential and by so 
doing, gain an insight into the process by which PV affects mitochondria.
The PV non-structural proteins 2B and 2BC were considered most likely to play a 
role in these processes. These two proteins have been extensively associated with 
changes in membrane permeability and proliferation: Transient expression in 
mammalian cells causes an increase in the plasma membrane permeability (Doedens 
& Kirkegaard, 1995; Aldabe et al., 1996). 2B, expressed in E.coli, has been found to 
increase the permeability of the bacterial cell membrane (Lama & Carrasco, 1992); 
(Lama & Carrasco, 1996). 2BC has been shown to cause an increase in intracellular 
[Ca^^Ji when transfected in cells infected with recombinant vaccinia viruses (Aldabe 
et al., 1997). The vesicle proliferation seen in PV infected cells has been found to be 
associated with 2BC; expression of 2BC in mammalian cells and Saccharomyces 
cerevisiae was shown to induce the proliferation of small membranous vesicles in the 
cytoplasm (Bienz et al., 1983; Cho et al., 1994; Aldabe & Carrasco, 1995; Barco & 
Carrasco, 1995), suggesting that these proteins might interact with lipid structures 
such as the mitochondria membranes. These findings led to the decision to explore
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the possibility that either 2B or 2BC may be responsible for the dysfunction of the 
mitochondria during PV infection.
This investigation used two approaches. Firstly to express the proteins in mammalian 
cells and study their effect in isolation and secondly to raise antibodies specific for 
these proteins in order to detect them and determine their intracellular localisation. 
To facilitate both approaches it was necessary to amplify the coding sequences of 2B 
and 2BC from PV genetic material by RT-PCR and clone them for expression.
4.2 Cloning of the 2BC and 2B coding sequences
Standard molecular biological techniques were used for the cloning of the sequences 
encoding proteins 2BC and 2B. DNA encoding each of the two non-structural 
proteins was selectively amplified by PCR. The oligonucleotides used as primers for 
PCR were designed to insert start and stop codons flanking each sequence. EcoRl 
sites were also added upstream and downstream of the coding regions. The primers 
2BCstart (sense) and 2BCend (anti-sense) were used to amplify the 2BC gene whereas 
primers 2BCstart and 2Bend (anti-sense) were used for amplification of the 2B gene 
(table 4.1).
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2BQ,art I '^g a a g a a  t t q a c g g a a a t g g g c a t c a c c a a t t a c a t a g a g t -'' 
2BCa„d ^'GGAGAATTdATTGAAACAAAGCCTCCATACAATTGCC 
2Be„d ®'CCAGAATTCACAGTTTAATAACATAGGGAAT
Table 4.1 Sequence of the three primers, 2BCstart? 2BCend? and 2Bend used for 
the cloning of the genes corresponding to the 2BC and 2B proteins. The shaded 
region identifies the EcoRl recognition sequence, the bold region identifies the 
introduced start codon, and the underlined regions identify stop codons.
Amplified sequences were cloned into the MCS of pTZ19R linearised at the unique 
EcoRl site. pTZ19R is a small phagemid 2,862 bp in length, which was constructed 
by inserting the DNA of phage fl intergenic region in pUC19 (a small high copy 
E.coli plasmid). pTZ19R (fig 4.1) contains: MCS between 614-671 bp; a T7 
promoter inserted near the MCS; a pMBl replicon rep responsible for the replication 
of the phagemid; the bla gene, coding for beta-lactamase that confers resistance to 
ampicillin; the lacZ gene encoding the N-terminal of beta-galactosidase allowing 
blue/white screening of recombinant phagemids; phage fl intergenic region required 
for initiation and termination of phage fl DNA synthesis (+ and -  strands) and for 
packaging of DNA into bacteriophage particles.
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Figure 4.1 Diagram of the pTZ19R vector map and its MCS.
(www.fermentas.com/techinfo/NucleicAcids/mapptzl9u.htm)
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4.2.1 Cloning of the 2BC coding sequence
The 2BC coding sequence was produced by RT-PCR amplification of PV mRNA. 
RNA was extracted from Vero cells infected with polio I (section 2.7). cDNA was 
synthesised using reverse transcriptase and the primer 2BCend (anti-sense) (table 4.1). 
The detailed protocol is described in section 2.9.2.1. The single stranded cDNA 
produced was then amplified in a standard PCR reaction using the primers 2BCstart 
and 2BCend and Taq DNA polymerase (section 2.9.2.2). The PCR products were 
electrophoresed on a 1.2% agarose gel (section 2.8.5) alongside DNA size markers. 
A prominent band was observed that migrated to a distance corresponding to the 
expected size of the sequence encoding 2BC (approximately 1,355 bp) (fig 4.2, lane 
8).
3 4 5 6 7 8
1.98 —
Figure 4.2 1.2% agarose gel of PCR products generated to contain the 2BC
coding sequence. Lane 8: band indicated by arrow corresponds to the expected size 
for 2BC. Lane 1: X DNA size markers, lanes 2-8: products of 7 reactions.
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The PCR product was purified (section 2.S.2.3), and attempts to ligate it into the 
EcoRl site of pTZ19R were not successful. Therefore, blunt-ends were generated 
using T4 DNA polymerase (section 2.8.3.2). The blunt-ended product was then 
purified by gel extraction (section 2.8.2.3) and its concentration estimated by 
electrophoresing a known volume alongside XDNA markers of known concentration 
(section 2.8.5). The final cDNA product was ligated (as described in section 2.8.3.4) 
into vector pTZ19R that had been Smal digested (section 2.8.3.1), dephosphorylated 
(section 2.8.3.3) and purified (section 2.8.2.3). The products of the ligation reaction 
were transformed into E.coli DH5a cells (section 2.8.4) and recombinant cells were 
selected by the blue/white colony test (section 2.8.4.2). Plasmids from the white 
colonies were isolated (section 2.8.1.2) and the presence of the insert was examined 
by restriction enzyme digestion followed by agarose gel electrophoresis.
The primers used for the production of the 2BC cDNA were designed to introduce 
EcoRl sites on either end of the cDNA. PTZ19R also has an EcoRl on the MCS 
16bp upstream of the Smal site (fig. 4.1). Therefore, EcoRl was used to screen for 
the presence of an 1.3kb fragment diagnostic of the 2BC cDNA cloned into pTZ19R. 
Eight colonies were screened. As shown in figure 4.3 the plasmid in lane 4 yielded 
an approximately 1.3kb fragment following EcoRl digestion.
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Figure 4.3 1.2% agararose gel of EcoRl digested recombinant pTZ19R/2BC
plasmids. Lane 1: X DNA size markers, lanes 2-4: plasmids derived from 3 white 
colonies. Arrow indicates the expected 1.3kb fragment diagnostic of the 2BC cDNA 
cloned into pTZ19R. Note that the digestion shown in lane 4 is not complete and 
the top of the 3 bands corresponds to the relaxed form of the undigested recombinant 
plasmid.
The colony that yielded the recombinant plasmid shown in lane 4 (fig. 4.3) was 
cultured further and the plasmid was extracted and purified (section 2.8.1.3) for 
subsequent sequencing. The universal primers shown in table 4.2 and an automated 
sequencer were used as described in section section 2.10.
M l3 forward 
M l3 reverse
TGTAAAACGACGGCTATGACC
CAGGAAACAGCTATGACC 3 ’
Table 4.2 The universal primers M13 forward and M13 reverse.
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Results obtained using the M13 forward primer confirmed that the ATG start codon 
had been successfully introduced at the 5’ end of the 2BC cDNA (fig. 4.4a). 
Moreover, the EcoRL site in the 2BCstart primer had been mutated in the actual cDNA 
sequence by loss of the first two bases. Using the M l3 reverse primer it was shown 
that both the stop codon TGA and the EcoRL site were successfully introduced at the 
other end of the insert (fig 4.4b).
2BC insert»TZ19R
KpnllEcoPS. start codon
AC! r G A AT T A G  C r CG G T ^ C C C  A T T C A C ^ Q  A A A T  G Q Q  A C  C A  A I Î ^ O A  T A G A C T  C | ^ C
a M
b)
2BC insert(TZ19R
2 BC^  ^primer
stop codonEcoM
C T A G ^ G G A T C C C C G ^ Q  A A T | l  C À | T A A A C A A AG C ^ ^ T C  CA T A CA A . y  G C C A A T (
Figure 4.4 Sequence chromatograms of the pTZ19R/2BC recombinant clone.
a) Chromatogram using the M l3 forward primer.
b) Chromatogram using the M13 reverse primer which reads the reverse 
complement of the sequence. Note that the TCA is the reverse 
complement of the TGA stop codon. AEcoRl: mutated EcoRl,
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4.2.2 Cloning of the 2B coding sequence
pTZ19R containing 2BC cDNA was also used as a template to amplify the 2B 
coding sequence by PCR. The primers 2BCstart and 2Bend and Taq polymerase were 
used as described in section 2.9.3. The PCR products were electrophoresed on a 2% 
agarose gel (section 2.8.5) alongside DNA size markers in order to verify the 
presence of 2B cDNA. The expected size of this PCR product is approximately 282 
bp. A band of similar size was observed (fig. 4.5, lane 3).
0.56 —
Figure 4.5 2% agarose gel of PCR products generated to contain the 2B
coding sequence. Lane 1: X DNA size markers, lanes 2-3: products of 2 reactions. 
Arrow indicates the expected 282bp fragment diagnostic of the 2B cDNA.
Blunt-ends were generated and the 2B cDNA PCR product was ligated into the Smal 
site of pTZ19R as before. EcoRl restriction digestions were carried out to screen a 
number of recombinant colonies for the presence of the 282 bp 2B cDNA fragment. 
Figure 4.6 shows that the plasmid in lane 7 exhibited the expected restriction pattern.
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Figure 4.6 2% agararose gel of EcoRl digested recombinant pTZ19R/2B
plasmid. Lane 1 : X DNA size markers, lanes 2-7 different digested plasmids. Arrow 
indicates the expected 282bp fragment diagnostic of the 2B cDNA in lane 7.
Subsequent sequencing, carried out as described in section 4.2.1, of the plasmid 
containing the 2B cDNA confirmed that the ATG start codon as well as the TGA 
stop codon were successfully introduced. In addition, it was shown that the EcoRl 
site was successfully introduced in the 3’ end of the 2B cDNA whereas the EcoRl 
site that was present in the 2BCstart primer was mutated by loss of 3 bp (fig 4.7).
108
Chapter 4
a) pTZ19R 2B insert<
2BC^^ primer
EcoRL Kpnll AEcom start codon
: C  A <3 I Q  A T C O A G C T  T A C C C A I C  ^ C G  G  A A A T G  G A 1 C  A C C  A A C A T A C  A T  V^(
ikhXiuLmmiv
b) 2B insert(TZ19R
2B^  ^primer
EeoRl stop codon
A A T C T C C  A
Figure 4.7 Sequence chromatograms of the pTZ19R/2B recombinant clone.
a) Chromatogram using the M 13 forward primer.
b) Chromatogram using the M l3 reverse primer which reads the reverse 
complement of the sequence. Note that the ACT is the reverse 
complement of the TGA stop codon.
109
Chapter 4
4.3 Expression of 2BC and 2B genes in mammalian cells
The mammalian cell lines used to examine the effects PV has on cellular respiration 
and mitochondrial function were COS-1 and T47D. However, T47D are not easily 
transfected hence, only the COS-1 cell-line was used to express 2B and 2BC and 
study their effect on mitochondrial function. COS-1 cells are fibroblasts transformed 
with a replication origin-defective mutant of SV40, which can encode the wild-type 
T antigen. Therefore these cells express T antigen but are unable to replicate the 
SV40 DNA (Gluzman, 1981). In order to express 2BC and 2B, the genes must be 
sub-cloned into a vector capable of replicating in these cells. SV40 based vectors 
fulfil this criterion since they contain an SV40 origin of replication that allows for 
introduced DNA to be replicated to high copy numbers as well as an early promoter 
which allows for the transient expression of high quantities of the desired proteins in 
these cells.
4.3.1 Sub-cloning of 2BC and 2B coding sequences into a mammalian 
expression vector
The expression vector used for the sub-cloning was the SV40 based vector pUSlOOO 
(fig. 4.8). It is 5,421 bp in length and it contains: an SV40 origin of replication that 
allows the vector to be replicated to a high copy number (2-4 x 10  ^ copies/cell); the 
SV40 early promoter region driving transcription of the xanthine-guanine 
phosphoribosyl transferase gene gpt from pSV2gpr (Whittle et a l, 1987); a strong 
promoter/enhancer transcriptional control element from the human cytomegalovirus 
(hcmv); a MCS between 605-658 bp; and an ampicillin resistance marker.
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Figure 4.8 Map of the pUSlOOO vector.
The vector was linearised by digestion at the unique EcoRl restriction site (section 
2.8.3.1), dephosphorylated (section 2.S.3.3) and purified (section 2.S.2.3). The 2BC 
and 2B cDNA molecules were excised by EcoRl digest of the pTZ19R/2BC and 
pTZ19R/2B constructs respectively and gel purified (section 2.S.2.3). Each insert 
was then ligated into the linearised vector and the products of the ligation reactions 
were transformed into E.coli DH5a cells (section 2.8.4). Numerous transformants 
were tested for the presence of the 2BC and 2B cDNA fragments and those in the 
desired orientation in the vector were determined by restriction enzyme digestion 
using the enzyme Kpnll followed by gel-electrophoresis. As illustrated in figure 4.9
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correct insertion of the 2BC and 2B cDNA would result in the generation of 2,231 bp 
and 1,156 bp fragments respectively following Kpnll digestion. Figure 4.10 shows 
the Kpnll restriction pattern of six 2BC/pUS1000 constructs two of which (lanes 7 
and 8) exhibited the expected band of 2,231bp. Similarly lanes 3 and 4 in figure 4.11 
show a band of a size similar to the expected 1,156 bp for the 2B/pUS1000 construct. 
The correct constructs were further amplified sand used for examining the expression 
of the 2BC and 2B proteins in COS-1 cells (section 4.4).
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Figure 4.9 Restriction maps showing the relative Kpnll positions.
a) 2BC/pus 1000 desired orientation
b) 2BC/pUS 1000 wrong orientation
c) 2B/pUS 1000 desired orientation
d) 2B/pUS 1000 wrong orientation
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Figure 4.10 1.2% agarose gel of 2BC/pUS1000 constructs digested with Kpnll,
Lane 1: X DNA size markers, lanes 6 & 7: 2BC/pUS1000 desired orientation 
(indicated by arrow), lanes 3 & 4: 2BC/pUS1000 wrong orientation.
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Figure 4.11 1.2% agarose gel of 2B/pUS1000 constructs digested with Kpnll.
Lane 1: DNA size markers, lane 3 & 4: 2B/pUS1000 desired orientation (indicated 
by arrow), lanes 5-7: 2B/pUS1000 wrong orientation.
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4.3.2 Expression of 2BC and 2B proteins in COS-1 cells
The 2BC/pUS1000 and 2B/pUS1000 constructs were transfected into COS-1 cells 
using lipofectin® reagent as described in section 2.15.1. pUSlOOO alone was used as 
a control. The vector pCHllO expressing the lacZ gene that encodes for p-gal was 
used to estimate the transfection efficiency (section 2.15.2). This was found to be 
40%. Figure 4.12 shows COS-1 transfected with pCHl 10.
%
Figure 4.12 COS-1 cells transfected with pCHllO. COS-1 cells were 
transfected with pCHllO and stained with X-gal and visualised under a light 
microscope (section 2.15). Cells expressing are stained blue. Magnification: 400 x.
The successful expression of 2B and 2BC was verified by Northern blotting. RNA 
was extracted from the cells transfected with either of the two constructs as described 
in section 2.7, and northern blotted (section 2.11) to confirm the transcription of the 
2BC and 2B genes. 2B cDNA was amplified by PCR (section 4.2.2), gel-extracted
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(section 2.8.2.3), radiolabelled with (section 2.11.3) and used as the probe for the 
detection of both 2BC and 2B RNA molecules. The autoradiograph shown in figure 
4.13 demonstrates that both 2BC and 2B genes were successfully transcribed.
bp 
6,583 —
*
1,908 —
623
Figure 4.13 Northern blot of 2B and 2BC RNA. RNA extracted from COS-1 
cells transfected with 2BC/pUS1000 construct (lanel) and 2B/pUS1000 construct 
(lane 2) and probed with ^^ P radiolabelled 2B cDNA. Lane 3: total RNA. Arrows 
indicate the probed bands.
4.3.3 Effects of the expression of 2BC and 2B proteins on the mitochondrial 
membrane potential
COS-1 cells were grown in 6-well plates on round glass coverslips and transiently 
transfected with 2BC/pUS1000 and 2B/pUS1000 (section 2.15.1). Mock-infected 
cells that had been treated in the same way except for the absence of poliovirus were
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used as controls. At 48 hr post-trasnfection the coverslips were washed with medium 
and incubated (15min) at 37 °C with 1 ml normal growth medium supplemented with 
O.SpM TMRE (section 2.4). TMRE fluorescent images were then recorded and 
digitised for analysis of pixel intensity using MCID software as described in section 
2.4. COS-1 cells transfected with vector were used as control. The data analysed 
showed a significant increase in TMRE fluorescence in cells expressing 2B as shown 
in figure 4.14. The average pixel intensity of TMRE was found to be double in 
infected cells in comparison to control cells {P< 0.05). The increase in the pixel 
intensity observed in cells expressing 2BC was not significantly different to that 
observed in control cells.
S  25
41 1 0
control 2BC 2B
Figure 4.14 TMRE fluorescence in COS-1 cells expressing 2B and 2BC.
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4.4 Expression of 2BC and 2B genes in bacterial cells
In order to raise antibodies against a particular protein, that protein has to be highly 
purified and available in relatively large amounts. A widely used method for protein 
purification is to create fusions of the DNA that encodes for the desired antigen with 
a gene whose product can be easily identified and isolated by affinity 
chromatography. The fusion gene used in this study was GST, encoding a 29 kDa 
protein, which can be easily purified from bacterial lysates by affinity 
chromatography on Glutathione Sepharose columns. Expression of the 2BC and 2B 
coding sequences was achieved using GST fusions in the pGEX GST gene fusion 
vectors.
4.4.1 Sub-cloning of 2BC and 2B coding sequences into GST gene fusion 
vectors
The gene fusion vectors were chosen to allow cloning of the two coding sequences in 
the correct reading frame for expression as fusion proteins. pGEX-4T-2 and pGEX- 
4T-3 were used to sub-clone the 2BC and 2B genes respectively. As shown in figure
4.15 these vectors are approximately 4,970 bp in length and contain: a pBR322 site 
of replication initiation; a GST gene region (carrying a tac promoter for chemically 
inducible, high-level expression; a lac operator; a ribosome binding site for GST; and 
an AT G start codon for GST); a MCS (at 930-965 bp in pGEX-4T-2, 930-967 bp in 
pGEX-4T-3); a lacP gene which provides a high level repressor to ensure that there 
is sufficient repression even with a high-copy number vector; an Amp'' gene 
confering resistance to ampicillin.
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Figure 4.15 Maps of the GST fusion vectors and their MCS.
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EcoRl digested and purified 2BC and 2B genes were ligated into the unique EcoRl 
site of pGEX-4T-2 and pGBX-4T-3 respectively following a sub-cloning protocol 
similar to that described in section 4.3.1. The products from the ligation reactions 
were transformed in E.coli DH5a cells (section 2.8.4) and the successful insertion of 
the genes into their respective vectors was verified by restriction digestions with 
EcoRl (section 2.8.3.1). The correct orientation of the genes within the vectors was 
then examined by restriction digests that included both Kpnll and Pstl. Correct 
insertion of the 2BC and 2B cDNA will generate fragments of 2,306 bp and 1,238 bp 
respectively (fig. 4.16). Lanes 3 and 4 on the agarose gel shown in figure 4.17 
exhibit the expected band for the 2BC/pGEX-4T-2 construct. Additionally, the 
characteristic band for the 2B/pGEX-4T-2 constuct is shown in figure 4.18.
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Figure 4.16 Restriction maps showing the relative jKpwII and Pstll positions in 
the pGEX-4T-2 and pGEX-4T-3 constructs.
a) 2BC/pGEX-4T-2 desired orientation
b) 2BC/pGEX-4T-2 wrong orientation
c) 2B/pGEX-4T-3 desired orientation
d) 2B/pGEX-4T-2 wrong orientation
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Figure 4.17 1.2% agarose gel of 2BC/pGEX-4T-2 constructs digested with
Kpn\ and Pstll. Lane 1: X DNA size markers, lanes 3 & 4: 2BC/pGEX-4T-2 desired 
orientation (indicated by arrow), lane 2: 2BC/pGEX-4T-2 wrong orientation.
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Figure 4.18 1.2% agarose gel of 2B/pGEX-4T-3 constructs digested with Kpnl
and Pstll. Lane 1: size markers, lane 2: 2B/pGEX-4T-3 desired orientation 
(indicated by arrow).
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4.4.2 Expression of 2BC and 2B proteins in E.coli
Colonies containing the correct fusion constructs were further grown and induced by 
addition of IPTG during log phase growth, as described in section 2.14.1, to 
overexpress the fusion proteins. Cultures containing the vectors without insert were 
also induced as controls. The cultures were pelleted 5hr after induction, the cell 
pellets were lysed using SDS loading dye and part of each lysate was separated using 
10% SDS-PAGE (section 2.12s). Samples of uninduced cultures were used as a 
control. Expression of the desired fusion protein can be identified by the absence of 
the 29kDa GST and by the presence of a novel, larger fusion protein. The expected 
molecular weights are 77kDa and 38.5kDa for the fusion proteins 2BC/GST and 
2B/GST respectively. As shown in figures 4.19 and 4.20 the band corresponding to 
the expected size of GST alone was observed following induction of the empty 
vectors and lost when the fusion vectors were induced. However, following induction 
of the fusion vectors predominant bands of the expected sizes for the fusion proteins 
were not observed.
In order to further investigate the presence of the fusion proteins the lysates were 
electophoresed through a 10% SDS-PAGE and Western blotted onto nitrocellulose 
(section 2.13.1). The proteins were detected using the ECL detection method (section 
2.13.2): The primary antibody used was anti-GST purified from goat serum at a 
concentration 1:2000 diluted in rinse buffer containing 10% PCS, and the secondary 
was anti-goat IgG-HRP at 1:1000 in rinse buffer containing 10% PCS. This 
experimental procedure revealed the presence of expressed 2B/GST fusion protein 
following induction (fig. 4.22) but not that of 2BC/GST fusion protein (fig. 4.21). 
GST protein was present before and after induction of the empty vectors. It was not
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possible to further investigate the induced expression of 2BC fusion protein due to 
time constrictions.
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Figure 4.19 Kenacid blue stained 10% SDS-PAGE gel of the bacterial lysates 
containing the pGEX-4T-2 fusion vectors. 10 pi of each lysate were run.
Lane 1 : low Mr markers 
Lane 2: uninduced empty pGEX-4T-2 vector 
Lane 3 & 4: uninduced 2BC/pGEX-4T-2 vector 
Lane 5: induced empty pGEX-4T-2 vector 
Lane 6 & 7: induced 2BC/pGEX-4T-2 vector 
Lane 8: high Mr markers
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Figure 4.20 Kenacid blue stained 10% SDS-PAGE gel of the bacterial lysates 
containing the pGEX-4T-2 fusion vectors. 10 pi of each lysate were run.
Lane 1 : low Mr markers
Lanes 2 & 3: induced 2B/pGEX-4T-3 vector
Lane 4: induced empty pGEX-4T-3 vector
Lane 5: induced DH5a
Lane 6 & 7: uninduced 2B/pGEX-4T-3 vector
Lane 8: uninduced empty 2B/pGEX-4T-3 vector
Lane 9: induced E.coli DH5a
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Figure 4.21 Western blot of cell extracts following induction of the pGEX-4T- 
2 vectors. Extracts from cells expressing 2BC/GST were subjected to SDS-PAGE 
followed by immunoblotting with an anti-GST antibody.
Lane 1: uninduced empty pGEX-4T-2 vector 
Lane 2: induced empty pGEX-4T-2 vector 
Lane 3: uninduced 2BC/pGEX-4T-2 vector 
Lane 4; uninduced 2BC/pGEX-4T-2 vector 
Lane 5: induced 2BC/pGEX-4T-2 vector 
Lane 6: induced 2BC/pGEX-4T-2 vector
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Figure 4.22 Western blot of the fusion proteins following induction of the 
pGEX-4T-3 vectors. Extracts from cells expressing 2B/GST were subjected to 
SDS-PAGE followed by immunoblotting with an anti-GST antibody. Arrow 
indicates the 2B/GST fusion protein.
Lane 1 : induced empty pGEX-4T-3 vector 
Lane 2: induced 2B/pGEX-4T-3 vector 
Lane 3: induced 2B/pGEX-4T-3 vector 
Lane 4: uninduced empty pGEX-4T-3 vector 
Lane 5: uninduced 2B3/pGEX-4T-3 vector 
Lane 6: uninduced 2BC/pGEX-4T-2 vector
4.4.3 Cleavage of fusion proteins
Cleavage of the fusion proteins to separate 2B from GST was attempted using the 
method described in section 2.14.2. Electrophoresis of the purification products 
using 10% SDS-PAGE and Kenacid blue staining did not reveal any cleaved 
proteins. Due to time restrictions it was not possible to carry out different procedures 
of cleavage or screening for the cleaved products.
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4.5 Summary
cDNA sequences coding for the non-structural proteins 2B and 2BC were amplified 
by RT-PCR and PCR methods from poliovirus genetic material. They were 
subsequently cloned and sub-cloned into appropriate cloning and expression vectors 
and these steps were verified by sequencing and restriction digestion analysis.
The 2B and 2BC coding sequences were transiently transfected in COS-1 cells 
successfully and the effect of their expression on mitochondrial membrane potential 
(A\j/m) was investigated using the fluorescence probe TMRE. A significant increase 
in TMRE fluorescence was observed in cells transfected with 2B/pGEX-4T-3 
construct compared to cells transfected with pGEX-4T-3 alone. However expression 
of 2BC did not significantly alter the TMRE fluorescence. This evidence suggests 
that 2B may be the factor responsible for the increase in mitochondrial membrane 
potential that was observed in poliovirus-infected cells (section 3.4).
Work to generate antibodies specific for 2B and 2BC was initiated. A GST gene 
fusion system was utilised for the expression and purification of the 2B and 2BC 
proteins in E.coli. The 2B/GST fusion protein was successfully expressed, however 
the 2BC/GST protein was not detected following expression. Purification of the 2B 
fusion protein was attempted.
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Chapter 5 
DISCUSSION
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Enteroviruses, including poliovirus, have been linked to the development of CES and 
post-polio fatigue syndrome and a mitochondrial disorder precipitated by a virus 
infection has been suggested as the cause for the unexplained fatigue in CES. 
Abnormal mitochondria in CES patient muscle biopsies and abnormalities in cellular 
energy levels suggestive of an impairment of mitochondrial function following 
infection have been observed (reviewed in chapter 1). Therefore, it is reasonable to 
suggest that the apparent inability to generate adequate energy in muscle tissue is 
related to a virus-induced impairment of the mitochondrial electron transport chain.
Consequently, the mitochondrial function of two mammalian cell lines following 
infection with PV was investigated and the virus was found to have a novel effect on 
cellular respiration. Upon infection with PV, the basal respiratory rate of both cell 
lines decreased. This inhibition in cellular respiration was attributed to a block of 
electron transport around complexes II and III. The observed inhibition of succinate 
dehydrogenase activity indicated that complex II was the major target of poliovirus 
infection. Electron flow through cytochrome c remained intact since respiration was 
almost completely recovered following the addition of TMPD and ascorbate. 
Eurthermore, addition of exogenous cytochrome c did not stimulate respiration any 
further which concludes that cytochrome c remains associated physically and 
functionally with mitochondria during infection. This is in contrast to apoptosis, 
where cytochrome c is translocated from mitochondria to the cytosol where it forms 
a caspase activiting complex through the interaction with several proteins including 
Apaf-1 and pro-caspase-9 (Green & Reed, 1998; Li et al., 1997; Yang et al., 1997). 
This observation together with the absence of an increase in plasma membrane 
permeability and rounding of the cells until eight hours after infection (Dr C.R.
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Johnson, personal communication) excludes apoptosis as the cause of the inhibition 
of respiration caused by poliovirus. This further re-enforces the suggestion that 
cytopathic effects caused by enteroviruses may be distinct from apoptosis (Agol et 
a l, 1998; Carthy et a l, 1998).
Although the fsevef^nhibition of SDH activity appears to be the cause for the 
inhibition of respiration during poliovirus infection, additional sites of inhibition 
between SDH (complex II) and complex III cannot be ruled out, given that the short­
lived recovery in SDH activity at 4hr was not accompanied by a similar increase in 
mitochondrial respiration. The involvement of additional effects on mitochondria is 
further corroborated by the observation that the loss of mitochondrial respiration was 
not accompanied by a drop in suggesting that the cells responded to PV 
infection with an increase in A\|/m despite the severe inhibition of respiration.
The intensity of fluorescence using TMRE depends primarily on the number of 
TMRE molecules sequestered by mitochondria. Thus, the increase in TMRE 
fluorescence should reflect an increase in Ai)/m. However, TMRE is also influenced 
by dye proximity, and a highly localised concentration can lead to fluorescence 
quenching (Metivier et al., 1998; Duchen & Biscoe, 1992). Mitochondrial swelling 
has been observed in the final stages of enterovirus infection (Shigesato et al., 1995; 
Marcato et al., 1992; Petruccelli et al., 1991), and thus subtle changes in 
mitochondrial matrix volume cannot be excluded early in infection. If occurring, 
these could influence TMRE fluorescence by altering the intermolecular proximity 
between TMRE molecules and hence account for the increase in fluorescence 
intensity. However, previous work suggests that this is unlikely to be the case. The
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Johnson, personal communication) excludes apoptosis as the cause of the inhibition 
of respiration caused by poliovirus. This further re-enforces the suggestion that 
cytopathic effects caused by enteroviruses may be distinct from apoptosis (Agol et 
ah, 1998; Carthy e/a/., 1998).
Although the inhibition of SDH activity appears to be the cause for the inhibition of 
respiration during poliovirus infection, additional sites of inhibition between SDH 
(complex II) and complex III cannot be ruled out, given that the short-lived recovery 
in SDH activity at 4hr was not accompanied by a similar increase in mitochondrial 
respiration. The involvement of additional effects on mitochondria is further 
corroborated by the observation that the loss of mitochondrial respiration was not 
accompanied by a drop in A\j/m, suggesting that the cells responded to PV infection 
with an increase in Arj/m despite the severe inhibition of respiration.
The intensity of fluorescence using TMRE depends primarily on the number of 
TMRE molecules sequestered by mitochondria. Thus, the increase in TMRE 
fluorescence should reflect an increase in A\|/m. However, TMRE is also influenced 
by dye proximity, and a highly localised concentration can lead to fluorescence 
quenching (Metivier et al., 1998; Duchen & Biscoe, 1992). Mitochondrial swelling 
has been observed in the final stages of enterovirus infection (Shigesato et al., 1995; 
Marcato et al., 1992; Petruccelli et al., 1991), and thus subtle changes in 
mitochondrial matrix volume cannot be excluded early in infection. If occurring, 
these could influence TMRE fluorescence by altering the intermolecular proximity 
between TMRE molecules and hence account for the increase in fluorescence 
intensity. However, previous work suggests that this is unlikely to be the case. The
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mitochondrial membrane potential probe tetraphenylphosphonium ion (TPP^) 
(Lotscher et al., 1980) can be used to monitor A\|/m in cells radiometrically using the 
tritiated derivative of TPP^ in the absence of spectral interferences (Andersson et al., 
1987; Budd & Nicholls, 1996). Studies with this system have yielded data in 
agreement with the results presented in this study. Additionally, work by others has 
shown that there is no decrease in Arj/m in poliovirus infected HeLa cells until plasma 
membrane damage has occurred (Lacal & Carrasco, 1982; Schaefer et al., 1982). 
Furthermore, a transient increase in TPP^ sequestration in response to poliovirus 
infection was observed. It is unclear how PV-infected cells can maintain a high A^m 
under conditions where respiration is inhibited. Perhaps noteworthy in this context 
are data from a study of hepatocytes exposed to anoxia. This found that A\|/m could 
be maintained in the absence of respiration and without ATP hydrolysis by 
mitochondrial ATP synthase (Andersson et ah, 1987). In the present study it was 
observed that ATP levels were not depleted after infection in T47D cells suggesting 
that Avj/m may not be maintained through a reversal of ATP synthase activity. This 
lack of ATP depletion has also been observed in HeLa cells infected with poliovirus 
(Schaefer et al., 1982). Another possible means by which Ai|/m might be is through 
some effect between viral proteins and the cellular protein Bcl-2 and this is discussed 
below.
The PV non-structural proteins 2B and 2BC have been found to induce both 
alterations in cell membrane permeability and proliferation of these structures 
(Aldabe et al., 1996; Aldabe & Carrasco, 1995; Barco & Carrasco, 1995; Cho et al., 
1994; Doedens & Kirkegaard, 1995; Lama & Carrasco, 1992; Lama & Carrasco, 
1996). This type of finding clearly implies that such proteins must be capabale of
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interaction with the lipid structures of internal cell membranes. However it is not 
clear that this ability might extend to mitochondria membranes. This question was 
approached by expressing 2B and 2BC in COS-1 cells and the effects they had on 
mitochondrial Av|/m were investigated. This work also requires the determination of 
the intracellular localisation of these proteins when expressed and this was attempted 
by raising mono-specific antisera against each protein. Unfortunately, although this 
work was initiated, time constraints prevented its completion.
Both approaches required the amplification of the sequences coding for each of the 
proteins from PV genetic material and their subsequent expression in mammalian 
and bacterial cells. cDNA coding for the PV non-structural protein 2BC was 
selectively amplified by RT-PCR. The RNA used was isolated from Vero cells 
infected with Mahoney strain of type 1 poliovirus. The primers used for the reaction 
were designed to introduce EcoRl sites upstream and downstream of the coding 
sequence to facilitate its insertion into cloning and expression vectors. However, 
attempts to ligate the PCR product into the unique EcoRl site of the cloning vector 
pTZ19R were unsuccessful. Therefore, the ends of the PCR fragment were made 
blunt and it was ligated successfully into the unique Smal site of the vector. 
Although ligation of a random blunt-ended fragment into the Smal site resulted in the 
destruction of the lacZ gene, thus enabling the blue/white test, the Smal site itself 
was also destroyed. Therefore, Smal digestion could not be used to identify the 
clones containing the 2BC insert, hence, EcoRl digestion was used instead. Analysis 
by automated sequencing showed that the EcoRl site at the 5’ end of the 2BC coding 
sequence was destroyed thus explaining the failure of the PCR product to be ligated 
into the EcoRl site of pTZ19R. However, the unique EcoRl site of the vector is 20
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bp upstream of the destroyed EcoRl site which, allowed for the identification of the 
correct clone and for the extraction of the fragment and its subsequent insertion into 
the expression vectors. pTZ19R containing 2BC cDNA was used as a template to 
amplify the sequence coding for the PV non-structural protein 2B using the same 
sense primer (2BCstart) also used for 2BC amplification and an anti-sense primer 
designed to introduce an EcoRl site downstream of the coding sequence. The PCR 
fragment was also ligated into the Smal site of pTZ19R and sequencing showed that 
the 5’ EcoRl site was also destroyed. Additionally, sequence analysis of both 2B and 
2BC genes showed that the start and stop codons contained in the primers were 
successfully introduced.
2B and 2BC cDNA were ligated into the unique EcoRl site of the shuttle vector 
p u s  1000 and successfully transfected into COS-1 cells. The conditions used were 
optimised to give 40% transfection efficiency using a vector expressing lacZ. 
Transfections could not be performed using T47D cells since the transfection 
efficiency was very low (<5%). Examining the presence of 2B and 2BC RNA by 
Northern blots showed that both sequences were successfully transcribed. Western 
blot analysis to directly verify the presence of the proteins could not be performed 
because the necessary anti-serum against either of the proteins was not available. 
Measurements of mitochondrial Av|/m using TMRE revealed that the expression of 2B 
resulted in a significant increase in mitochondrial membrane potential in COS-1 cells 
(fig. 4.13). The extent of increase was similar to that previously observed in COS-1 
cells infected with PV (Dr C.R. Johnson, personal communication), suggesting that 
2B may be responsible for the increased Av|/m in the PV-infected cells. In contrast.
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the data obtained from the cells expressing 2BC was not significantly different to that 
of control cells not expressing the protein, although a small increase was observed.
Given that 2B induces the same effect on mitochondrial membrane potential, it is 
plausible to propose that it is the expression of this protein that is responsible for the 
increase in A^m observed in PV-infected cells. However, the contribution of 
additional virus proteins cannot be excluded. The molecular mechanisms responsible 
for the increase in A^mby 2B remain unclear, and this demands further study. It has 
been shown that 2B, when transiently expressed, enhances membrane permeability 
(Aldabe et al., 1996). Therefore, 2B may cause the formation of channels in the 
mitochondrial membrane that would allow increased uptake of anions across (or 
selective efflux of protons or other cations), and this would have the net effect of 
increasing A^m- Alternatively, the activity of the FiFo-ATPase might be altered by 
2B. Other studies have reported alterations in mitochondrial structure and function 
caused by viral proteins. Studies in yeast have shown that expression of the human 
immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) leads to mitochondrial 
dysfunction displayed in the loss of respiratory chain complex I, II, III, IV and citrate 
synthase activities (Macreadie et al., 1997b; Macreadie et al., 1997a). Additionally, 
Vpr has been shown to cause rapid dissipation of (Avj/m) and induce apoptosis via a 
direct effect of the mitochondrial permeability transition pore complex (Jacotot et ah, 
2000). Transient expression of hepatitis B virus X protein (HBx) has been shown to 
cause mitochondrial membrane potential alterations and high levels of HBx are the 
cause of abnormal mitochondria distribution involving clumping and aggregation of 
mitochondrial structures in cells (Takada et al., 1999; Henkler et al., 2001). Human 
T-cell leukemia virus type 1 (HTLV-1) encodes p i311, a protein shown to selectively
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target mitochondria and induce specific changes in their morphology (swelling) 
suggestive of alterations in the mitochondria metabolism (D'Agostino et a l, 2000). 
It should be emphasised that many of the above described experimental conditions 
are lethal to the mammalian cells or are known to induce apoptosis. Consequently, it 
is often difficult to rule out secondary post-mortem or apoptotic effects on 
mitochondria. However, this was clearly not the case in the present study where the 
observed mitochondria effects occurred well before any signs of toxicity or 
apoptosis. As shown in appendix II, apoptosis in COS-1 cells infected with PV was 
not observed until eight hours post-infection.
An attractive possibility would be that 2B has properties like the anti-apoptotic gene 
product Bcl-2 or might interact with Bcl-2. Bcl-2 is a cellular protein localised in 
several cellular compartments including the outer mitochondrial membrane 
(Monaghan et al., 1992; Lithgow et al., 1994; Akao et al., 1994; Krajewksi et al., 
1993), where it has been shown to maintain increased A\|/m in mitochondria by 
enhancing proton efflux thus preventing apoptosis (Vieira & Kroemer, 1999; 
Shimuzu et al., 1998). Bcl-2 exerts at least part of its apoptosis-regulated function 
by inhibiting the opening of the permeability transition pore (FTP) and delta psi 
dissipation (Susin et ah, 1999). FTP is localised to the contact sites between the 
inner and outer mitochondrial membranes. It is made of a large multiprotein 
complex comprising among others the voltage-dependent anion channel (VDAC, 
porin), adenine nucleotide translocator (ANT), mitochondrial cyclophilin D, the 
peripheral benzodiazepine receptor, hexokinase, creatine kinase and also the 
proapoptotic gene product Bax (Bemardi & Petronilli, 1996; Beutner et al., 1997). 
FTP behaves as a voltage-operated channel that becomes activated by high matrix
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Ca^ ,^ oxidative stress, pyridine nucleotide oxidation, thiol oxidation and low 
transmembrane potential. The transition of mitochondrial permeability involves 
opening and closing of FTP (Zoratti & Szabo, 1995; Huser et al., 1998). Likewise, 
2B could functionally resemble Bcl-2. This would not be unprecedented, since it is 
well known that a number of viruses (e.g. Ebstein-Barr virus, adenovirus, African 
swine fever virus) encode proteins that mimic the cellular function of Bcl-2 
(Kalvakolanu, 1999), and may stabilise the mitochondrial membrane barrier function 
hence, preventing apoptosis. Furthermore, Bcl-2 has been shown to have a high 
degree of similarity to the African swine fever gene LMW5-HL and to a lesser 
degree to the Epstein-Barr virus gene BHRFl (Hickish et al., 1994). Additionally, as 
shown in figure 5.1, the protein sequence of 2B displays 35% similarity and 20% 
identity to human Bcl-2 thus, supporting that 2B may be functionally similar to Bcl- 
2. An outline of the effects caused by PV on the function of mitochondria is 
presented in figure 5.2.
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Figure 5.1 Multiple sequence alignment of Human Bcl-2 with several viral 
proteins. The alignment was created using the ClustalW algorithm at the Baylor 
College of Medicine Search Launcher server. DDBJ/EMBL/GenBank accession 
numbers are as follows: LMW5-HL: (African Swine Fever Virus), Q07818; Bcl-2: 
(Homo Sapiens), AAA35591; BHRFl (Epstein-Barr Virus), P03182; 2B (Poliovirus 
type I), extracted from CAA24463.
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Expression of 2B and 2BC in E.coli was carried out using a glutathione-S-transferase 
gene fusion system. 2B and 2BC cDNA were ligated into the unique EcoRl sites of 
pGEX-4T GST fusion vectors and transformed into DH5a E.coli. Western blots 
showed that upon induction with IPTG a band corresponding to the fusion protein 
2B/GST was observed. However, 2BC/GST was not detected. This may be due to a 
number of reasons. The addition of the GST peptide on the 2BC protein might upset 
the normal folding pattern. However, the fusion protein should still have been 
observed in a denaturing SDS-PAGE protein gel that was used for Western blotting 
so this effect should be minor. Another possibility is that the addition of GST 
increases the susceptibility of 2BC to proteases and the fusion protein would then be 
degraded soon after translation. Alternatively, the fusion protein itself might be toxic 
to the bacterial cells. In support to this theory, inducible expression of 2BC in yeast 
cells has been shown to inhibit growth (Barco & Carrasco, 1995). Therefore it is 
possible that 2BC is cytotoxic in the present expression system. This also suggests 
that, since it is 2BC alone that is cytotoxic, further attempts to express it using 
alternative tagging constructs would be unsuccessful. Attempts to purify the 
2B/GST fusion protein by affinity chromatography were not successful. Time 
restrictions did not allow for the generation of antibodies for 2B and 2BC to be 
further carried out.
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6.1 Conclusions
The work presented in this thesis provides a potential link between CFS and viral 
infection by suggesting that the energy abnormalities in patients diagnosed with CFS 
may be due to a virus-induced impairment of the mitochondrial electron transport 
chain.
- A novel effect on cellular respiration caused by poliovirus infection was shown. 
Poliovirus infection produced a rapid decrease in cellular oxygen consumption. 
This virus-induced inhibition of cellular respiration was attributed to a block in 
the mitochondrial respiratory chain, which was located at complex II of the 
electron transport chain.
- Mitochondrial membrane permeability was increased by poliovirus infection and 
the non-structural poliovirus protein 2B may be responsible for this effect.
The first step in the production of antibodies specific for the 2B and 2BC 
proteins, in order to investigate their intracellular localisation, was carried out. 
2B was expressed successfully in bacterial cells however, 2BC could not be 
expressed, possibly due to its cytotoxic nature.
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6.2 Future work
Since 2B and possibly 2BC may be implicated in the change in mitochondrial 
membrane potential, their intracellular localisation should be investigated. 
Therefore, the immediate aim would be to find ways to specifically localise 2B and 
2BC following their expression within mammalian cells. The efforts to raise an 
antibody specific for 2B would be continued by purifying the 2B-GST fusion, 
cleaving off the GST peptide and injecting the purified 2B into a mouse or rabbit. 
Since 2BC could not be expressed in bacteria, an alternative expression system such 
as the baculovirus system could be utilised to raise a 2BC specific antibody.
Another approach for the detection of both proteins in mammalian cells would be to 
create fusions of 2B or 2BC with myc or histidine {His) peptides (tags) that can easily 
be detected with commercially available anti-myc and anti-7/z5 antibodies. For 
example a his-2Q fusion and a myc-2BC fusion could be expressed independently or 
together in mammalian cells and their localisation could be followed. Alternatively, 
2B or 2BC could be fused with the green fluorescent protein {gfp) that can be 
visualised in the cells without the need of an antibody. A drawback of these 
detection methods could be that the addition of the tags may possibly alter the 
folding of the proteins and hence their function.
Having established a method for the detection of the two proteins their intracellular 
localisation in relation to the mitochondria could be examined by using a 
mitochondria-specific dye (for example Mitotracker® red or green).
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Since expression of 2B alone had a similar effect on A\j/m as the total virus, it would 
be interesting to investigate the effect of 2B expression on mitochondrial respiration. 
However, a relatively large number of transfected cells would be required for 
measuring oxygen consumption therefore, an adenovirus transfection system could 
be utilised to ensure that most cells would express the 2B protein.
The mechanism of succinate dehydrogenase inhibition following PV infection could 
be explored. An anti-SDH antibody could be used in Western blotting analysis of 
extracts from infected and mock-infected cells in order to examine whether the levels 
of SDH are reduced following infection or whether proteolytic degradation. 
Similarly, SDH protein levels could be examined in cells as a function of 2B. In 
addition, in vitro cell-free experiments could be carried out using purified 
mitochondria and sub-mitochondrial particles and investigate the effect of 2B protein 
on a range of parameters, including oxygen consumption, A\|/m and SDH activity.
To further link the muscle abnormalities observed in CFS patients, known to have 
had a viral infection, with mitochondrial dysfunction, muscle biopsies and 
lymphocyte samples from these patients should be analysed. Levels of 
mitochondrial respiration, Ai|/m, and SDH activity could be investigated in a similar 
way to that described in this study.
The work presented here could be extended to include other viruses that have been 
linked to CFS. Such analysis would provide further insight into the relationship 
between viral agents, mitochondrial abnormalities and CFS.
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A ll
Gross nuclear morphology of COS-1 cells infected with PV as revealed by 
Hoechst-33342 staining. COS-1 cells were infected with polio I (section 2.3.3) 
andstained at 0 (a), 2 (b), 4 (c), 6 (d) and 8 (e) hours after infection as described in 
section 2.17. Arrows indicate apoptotic cells. Magnification: 400x.
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